検索:
徳島大学大学院医歯薬学研究部医学域医科学部門内科系呼吸器・膠原病内科学
徳島大学研究クラスター群研究クラスター群 (ミッション実現)2201005 がんの生存戦略の理解と刷新
徳島大学病院診療科内科呼吸器・膠原病内科
徳島大学医学部医学科生体防御腫瘍医学講座呼吸器・膠原病内科学分野
徳島大学医学研究科医学専攻生体防御腫瘍医学講座
徳島大学大学院医歯薬学研究部医学域連携研究部門(医学域)寄附講座系(医学域)地域リウマチ・総合内科学
徳島大学研究クラスター群研究クラスター群 (ミッション実現)2201002 慢性炎症の理解と操作
徳島大学研究クラスター群研究クラスター群 (登録)2203012 ミオパチー診断クラスター
(researchmapへのインポート用ファイル) [PDF解説] [researchmapへの自動反映について]

研究活動

個人のホームページ

専門分野

呼吸器内科学 (Respiratory Medicine)

研究テーマ

肺線維症に対する分子標的治療の開発に関する研究, 肺癌に対する特異的免疫療法の開発に関する研究 (肺線維症 (pulmonary fibrosis), 間質性肺疾患 (interstitial lung disease), 肺癌 (lung cancer), 癌免疫療法 (cancer immunotherapy))

著書・論文

著書:

1. 佐藤 正大, 西岡 安彦 :
進行性線維化を伴う間質性肺疾患の診断と治療,
南江堂, 2023年3月.
2. 西岡 安彦 :
特発性肺線維症,
株式会社 医学書院, 2023年1月.
3. 西岡 安彦 :
呼吸器疾患のバイオマーカー,
朝倉書店, 2022年3月.
4. 佐藤 正大, 西岡 安彦 :
特発性間質性肺炎,
日本臨牀社, 東京, 2021年10月.
5. 佐藤 正大, 西岡 安彦 :
呼吸細気管支炎を伴う間質性肺疾患(RB-ILD),
株式会社 中外医学社, 東京, 2021年8月.
6. 佐藤 正大, 西岡 安彦 :
非特異性間質性肺炎(NSIP),
株式会社 中外医学社, 東京, 2021年8月.
7. 西岡 安彦 :
呼吸器疾患のバイオマーカー,
朝倉書店, 東京, 2021年3月.
8. 佐藤 正大, 西岡 安彦 :
特発性器質化肺炎(COP/BOOP),
南江堂, 東京, 2021年3月.
9. 佐藤 正大, 西岡 安彦 :
Nintedanibの使い方と副作用対策,
南江堂, 東京, 2020年6月.
10. 豊田 優子, 西岡 安彦 :
ステロイド,
メディカルレビュー社, 東京, 2020年4月.
11. 西岡 安彦 :
肺胞微石症,
株式会社 医学書院, 2020年3月.
12. 佐藤 正大, 西岡 安彦 :
サルコイドーシス,
株式会社 医学書院, 2020年3月.
13. 佐藤 正大, 西岡 安彦 :
特発性間質性肺炎(その他の非特異性間質性肺炎,器質化肺炎),
日本医事新報社, 2019年7月.
14. 佐藤 正大, 西岡 安彦 :
間質性肺炎・過敏性肺炎,
株式会社 南山堂, 2019年5月.
15. 河野 弘, 西岡 安彦 :
膠原病の肺病変,
南江堂, 2019年4月.
16. 後東 久嗣, 西岡 安彦 :
血管新生阻害薬耐性機構,
南江堂, 2019年4月.
17. 西岡 安彦 :
好酸球性肺炎,
株式会社 医学書院, 2019年1月.
18. 小山 壱也, 西岡 安彦 :
テロメア伸長と肺線維症,
株式会社 中山書店, 東京, 2018年10月.
19. Hisatsugu Goto and Yasuhiko Nishioka :
ALK and Others: How Important Are ALK and Other Mutations in the Management of Lung Cancer?,
Springer, Jul. 2018.
20. 西岡 安彦 :
過敏性肺炎,
株式会社 医学書院, 2018年1月.
21. 豊田 優子, 西岡 安彦 :
ランゲルハンス細胞組織球症,
2017年10月.
22. 埴淵 昌毅, 西岡 安彦 :
分子生物学的にみた間質性肺炎および肺癌,
2017年10月.
23. 後東 久嗣, 西岡 安彦 :
肺胞微石症,
2017年10月.
24. 埴淵 昌毅, 西岡 安彦 :
じん肺症(珪肺,アスベスト肺),
2017年7月.
25. 西岡 安彦 :
間質性肺炎の急性増悪,
2017年1月.
26. 西岡 安彦 :
非特異性間質性肺炎(NSIP),
2016年12月.
27. 西岡 安彦 :
特発性肺線維症の基礎,
2016年3月.
28. 西岡 安彦 :
特発性間質肺炎,
2016年1月.
29. Yasuhiko Nishioka :
Pathogenesis of IPF. Is abnomal repair of epithelial damage involved in the basic pathogenesis of this disease?,
Springer, 2016.
30. Yasuhiko Nishioka :
Is abnormal repair of epithelial damage involved in the basic pathogenesis of this disease?,
Springer,Tokyo, 2016.
31. 後東 久嗣, 埴淵 昌毅, 西岡 安彦 :
先端医療シリーズ46. 呼吸器疾患診療の最先端. 全国主要呼吸器診療施設一覧. 徳島大学病院呼吸器・膠原病内科,
東京, 2015年8月.
32. 佐藤 正大, 西岡 安彦 :
細胞生物学,分子病態,
2015年.
33. 岸 潤, 河野 弘, 西岡 安彦 :
強皮症,
2014年9月.
34. 西岡 安彦 :
細胞・分子生物,
2014年5月.
35. 西岡 安彦, 青野 純典 :
安定期と増悪期の対応.,
克誠堂出版 株式会社, 2013年8月.
36. 西岡 安彦 :
特発性器質化肺炎.,
朝倉書店, 東京, 2013年6月.
37. 西岡 安彦 :
Fibrocyteと呼吸器疾患.,
医歯薬出版 株式会社, 東京, 2013年4月.
38. 西岡 安彦 :
症状と病態生理,
ヌーヴェルヒロカワ, 2013年3月.
39. 西岡 安彦 :
副腎皮質ステロイド薬,
南江堂, 2013年2月.
40. 西岡 安彦 :
肺線維化におけるfibrocyteの役割,
株式会社 中外医学社, 2013年1月.
41. 西岡 安彦 :
薬物療法,
株式会社 メジカルビュー社, 2012年5月.
42. 西岡 安彦 :
膠原病の肺合併症-検査の基本-,
医薬ジャーナル社, 大阪, 2012年2月.
43. 西岡 安彦 :
ベバシズマブ, --- 分子標的治療薬-最新の選び方・使い方- ---,
総合医学社, 2011年.
44. 木下 勝弘, 西岡 安彦 :
強勉の仕方-文献検索の仕方,医学論文の読み方・書き方,学会への取り組み方,大学院・医学博士・留学について, 呼吸器科医にとっての研究とは何か?-,
株式会社 診断と治療社, 2011年.
45. 中瀧 恵実子, 西岡 安彦 :
各種ガイドラインにおけるVAPの位置づけ,
2010年7月.
46. 西岡 安彦, 曽根 三郎 :
「肺サルコイドーシス」「過敏性肺炎」「肺胞蛋白症」「じん肺」,
南江堂, 東京, 2010年4月.
47. 西岡 安彦, 曽根 三郎 :
「肺サルコイドーシス」「過敏性肺炎」「肺胞蛋白症」「じん肺」,
南江堂, 2010年4月.
48. 西岡 安彦 :
膠原病における肺合併症の検査の基本,
2010年3月.
49. 中屋 豊, 桑波田 雅士, 丹黒 章, 土井 俊夫, 竹谷 豊, 野間 喜彦, 武田 英二, 東 博之, 島田 光生, 栗田 信浩, 大森 哲郎, 西 正晴, 青野 純典, 西岡 安彦, 吉本 勝彦, ほか 65名 :
NST用語ハンドブック,
メディカルレビュー社, 東京, 2006年2月.
50. 西岡 安彦, 兼松 貴則, 曽根 三郎 :
これだけは知っておきたい 癌の免疫化学療法, --- 免疫化学療法の目的とその評価法 ---,
医薬ジャーナル社, 大阪, 2005年5月.
51. 鵜飼 桃代, 西岡 安彦, 曽根 三郎 :
認定NSTガイドブック 日本病態栄養学会編, --- 呼吸器疾患に対する栄養管理 ---,
メディカルレビュー社, 2004年9月.
52. 西岡 安彦, 曽根 三郎 :
別冊『医学のあゆみ』 ARDSのすべて, --- ARDSと肺の繊維化 ---,
医歯薬出版 株式会社, 東京, 2004年3月.
53. 西岡 安彦, 曽根 三郎 :
よくわかる肺炎のすべて, --- 人工呼吸器関連肺炎 ---,
株式会社 永井書店, 大阪, 2003年12月.
54. 西岡 安彦, 曽根 三郎 :
よくわかる肺炎のすべて, --- 人工呼吸器関連肺炎 ---,
株式会社 永井書店, 大阪, 2003年12月.
55. 西岡 安彦 :
ダイナミック・メディシン 4, --- 胸壁・横隔膜腫瘍 ---,
西村書店, 2003年7月.
56. 西岡 安彦 :
ダイナミック・メディシン 4, --- 胸膜腫瘍 ---,
西村書店, 2003年7月.
57. 西岡 安彦 :
ダイナミック・メディシン 4, --- 胸膜炎 ---,
西村書店, 2003年7月.
58. 西岡 安彦 :
樹状細胞 ∼基礎から臨床へ∼, --- 樹状細胞の臨床応用 C.樹状細胞を標的とした免疫療法 1-b.遺伝子導入 ---,
南江堂, 東京, 2000年10月.
59. 西岡 安彦, 大串 文隆, 曽根 三郎 :
別冊 日本臨牀 領域別症候群シリーズ31, --- 免疫症候群 -その他の免疫疾患を含めて - (上巻) 特発性間質性肺炎・肺線維症 ---,
日本臨牀社, 大阪, 2000年.
60. T. Tutling, L. Zitvogel and Yasuhiko Nishioka :
DENDRITIC CELLS,
Academic Press, London, 1999.
61. 西岡 安彦, 曽根 三郎 :
Molecular Medicine 症候・病態の分子メカニズム, --- 肺転移 ---,
株式会社 中山書店, 東京, 1998年12月.
62. 西岡 安彦, 小倉 剛 :
気管支肺胞洗浄[BAL]法の臨床ガイドライン, --- 肺癌 ---,
克誠堂出版 株式会社, 東京, 1995年11月.

学術論文(審査論文):

1. Taku Takahashi, Yasushi Sato, Takanori Kashihara, Yoshihiro Miyata, Yasuteru Fujino, Yasuhiro Mitsui, Koichi Okamoto, Hiroshi Miyamoto, Yasuhiko Nishioka and Tetsuji Takayama :
Nintedanib-Induced Gastric Antral Vascular Ectasia in Patients with Idiopathic Pulmonary Fibrosis.,
ACG Case Reports Journal, Vol.10, e01107, 2023.
(DOI: 10.14309/crj.0000000000001107)
2. Takeshi Imakura, Seidai Satou, Kazuya Koyama, Hirohisa Ogawa, Takahiro Niimura, Kojin Murakami, Yuya Yamashita, Keiko Haji, Nobuhito Naito, Kozo Kagawa, Hiroshi Kawano, Yoshito Zamami, Keisuke Ishizawa and Yasuhiko Nishioka :
A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis.,
Respiratory Research, Vol.24, No.1, 2023.
(DOI: 10.1186/s12931-023-02446-x,   PubMed: 37269004)
3. Yasuhiko Nishioka, Sakae Homma, Takashi Ogura, Seidai Satou, Naoki Arai, Keisuke Tomii, Koichiro Kamio, Susumu Sakamoto, Yasunari Miyazaki, Hiromi Tomioka, Shu Hisata, Tomohiro Handa and Arata Azuma :
Exploratory phase 2 study of the novel oral multi-kinase inhibitor TAS-115 in patients with idiopathic pulmonary fibrosis.,
Respiratory Investigation, Vol.61, No.4, 498-507, 2023.
(DOI: 10.1016/j.resinv.2023.04.008,   PubMed: 37263115)
4. Atsushi Mitsuhashi, Kazuya Koyama, Hirokazu Ogino, Tania Afroj, Thi Na Nguyen, Hiroto Yoneda, Kenji Otsuka, Masamichi Sugimoto, Osamu Kondoh, Hiroshi Nokihara, Masaki Hanibuchi, Hiromitsu Takizawa, Tsutomu Shinohara and Yasuhiko Nishioka :
Identification of fibrocyte cluster in tumors reveals the role in antitumor immunity by PD-L1 blockade.,
Cell Reports, Vol.42, No.3, 112162, 2023.
(徳島大学機関リポジトリ: 118888,   DOI: 10.1016/j.celrep.2023.112162,   PubMed: 36870329)
5. Masaki Hanibuchi, Atsushi Mitsuhashi, Atsuro Saijo, Tatsuya Kajimoto, Seidai Satou, Tetsuya Kitagawa and Yasuhiko Nishioka :
receptor antagonist.,
The Journal of Medical Investigation : JMI, Vol.70, No.1.2, 281-284, 2023.
(DOI: 10.2152/jmi.70.281,   PubMed: 37164735)
6. Momoyo Azuma, Kazunori Oishi, Yukihiro Akeda, Saeko Morino, Yumi Motoki, Masaki Hanibuchi and Yasuhiko Nishioka :
Safety and immunogenicity of sequential administration of PCV13 followed by PPSV23 in pneumococcal vaccine-naïve adults aged ≥ 65 years: Comparison of booster effects based on intervals of 0.5 and 1.0 year.,
Vaccine, Vol.41, No.5, 1042-1049, 2022.
(徳島大学機関リポジトリ: 118625,   DOI: 10.1016/j.vaccine.2022.12.060,   PubMed: 36593171)
7. Seiya Ichihara, Hirokazu Ogino, Hiroto Yoneda, Keiko Haji, Kozo Kagawa, Kojin Murakami, Masato Mima, Yu Aoi, Atsushi Mitsuhashi, Yuki Tsukazaki, Yohei Yabuki, Ryohiko Ozaki, Seidai Satou, Hiroshi Nokihara and Yasuhiko Nishioka :
Immune checkpoint inhibitor-related pneumonitis with atypical radiologic features in a patient with anti-aminoacyl-tRNA synthetase antibody.,
Respiratory Medicine Case Reports, Vol.41, 101797, 2022.
(DOI: 10.1016/j.rmcr.2022.101797,   PubMed: 36583061)
8. Masaki Hanibuchi, Atsushi Mitsuhashi, Tatsuya Kajimoto, Atsuro Saijo, Seidai Satou, Tetsuya Kitagawa and Yasuhiko Nishioka :
Clinical significance of fractional exhaled nitric oxide and periostin as potential markers to assess therapeutic efficacy in patients with cough variant asthma.,
Respiratory Investigation, Vol.61, No.1, 16-22, 2022.
(DOI: 10.1016/j.resinv.2022.10.006,   PubMed: 36463016)
9. Muneo Numasaki, Koyu Ito, Kiyoshi Takagi, Kengo Nagashima, Hirotsugu Notsuda, Hirokazu Ogino, Rika Ando, Yoshihisa Tomioka, Takashi Suzuki, Yoshinori Okada, Yasuhiko Nishioka and Michiaki Unno :
Diverse and divergent functions of IL-32β and IL-32γ isoforms in the regulation of malignant pleural mesothelioma cell growth and the production of VEGF-A and CXCL8.,
Cellular Immunology, Vol.383, 104652, 2022.
(DOI: 10.1016/j.cellimm.2022.104652,   PubMed: 36516653)
10. Ryo Okuda, Takashi Ogura, Shu Hisata, Tomohisa Baba, Yasuhiro Kondoh, Takafumi Suda, Takeshi Johkoh, Tae Iwasawa, Hiromi Tomioka, Masashi Bando, Arata Azuma, Yoshikazu Inoue, Toru Arai, Yutaro Nakamura, Atsushi Miyamoto, Yasunari Miyazaki, Hirofumi Chiba, Haruyuki Ishii, Naoki Hamada, Yasuhiro Terasaki, Ichiro Kuwahira, Shinji Sato, Shingo Kato, Takuji Suzuki, Susumu Sakamoto, Yasuhiko Nishioka, Noboru Hattori, Naozumi Hashimoto, Satoshi Morita, Nao Ichihara, Hiroaki Miyata, Koichi Hagiwara, Toshihiro Nukiwa and Kunihiko Kobayashi :
Design and rationale of the Japanese Idiopathic Interstitial Pneumonias (JIPS) Registry.,
Respiratory Investigation, Vol.61, No.1, 95-102, 2022.
(DOI: 10.1016/j.resinv.2022.08.009,   PubMed: 36580379)
11. T Na Nguyen, Atsushi Mitsuhashi, Hirokazu Ogino, Hiroyuki Kozai, Hiroto Yoneda, Tania Afroj, Seidai Satou, Hiroshi Nokihara, Tsutomu Shinohara and Yasuhiko Nishioka :
S-1 eliminates MDSCs and enhances the efficacy of PD-1 blockade via regulation of tumor-derived Bv8 and S100A8 in thoracic tumor.,
Cancer Science, Vol.114, No.2, 384-398, 2022.
(徳島大学機関リポジトリ: 118295,   DOI: 10.1111/cas.15620,   PubMed: 36285504)
12. Naoki Kimura, Takuya Kawahara, Yukari Uemura, Tatsuya Atsumi, Takayuki Sumida, Toshihde Mimura, Yasushi Kawaguchi, Hirofumi Amano, Yukiko Iwasaki, Yuko Kaneko, Toshihiro Matsui, Yoshinao Muro, Yoshitaka Imura, Takashi Kanda, Yoshiya Tanaka, Atsushi Kawakami, Masatoshi Jinnin, Tomonori Ishii, Keiju Hiromura, Yusuke Miwa, Hiroshi Nakajima, Masataka Kuwana, Yasuhiko Nishioka, Akio Morinobu, Hideto Kameda and Hitoshi Kohsaka :
Branched chain amino acids in the treatment of polymyositis and dermatomyositis: a phase II/III, multi-centre, randomized controlled trial.,
Rheumatology, Vol.61, No.11, 4445-4454, 2022.
(DOI: 10.1093/rheumatology/keac101,   PubMed: 35179548)
13. Kozo Kagawa, Seidai Satou, Kazuya Koyama, Takeshi Imakura, Kojin Murakami, Yuya Yamashita, Nobuhito Naito, Hirohisa Ogawa, Hiroshi Kawano and Yasuhiko Nishioka :
The lymphocyte-specific protein tyrosine kinase-specific inhibitor A-770041 attenuates lung fibrosis via the suppression of TGF-β production in regulatory T-cells.,
PLoS ONE, Vol.17, No.10, e0275987, 2022.
(徳島大学機関リポジトリ: 118786,   DOI: 10.1371/journal.pone.0275987,   PubMed: 36301948)
14. Makoto Tobiume, Atsushi Mitsuhashi, Atsuro Saijo, Hirokazu Ogino, Tania Afroj, Hirohisa Ogawa, Hisatsugu Goto, Seidai Satou, Akane Abe, Keiko Haji, Ryohiko Ozaki, Hiromitsu Takizawa and Yasuhiko Nishioka :
Analysis of the chemotactic factors for tumor-infiltrating fibrocytes and their prognostic significances in lung cancer.,
Oncology Letters, Vol.24, No.5, 417, 2022.
(DOI: 10.3892/ol.2022.13537,   PubMed: 36245829)
15. Kenji Otsuka, Hiroshi Nokihara, Atsushi Mitsuhashi, Ryohiko Ozaki, Yohei Yabuki, Hiroto Yoneda, Hirokazu Ogino and Yasuhiko Nishioka :
Efficacy and safety of second-line chemotherapy for patients with advanced non-small cell lung cancer complicated by interstitial lung disease.,
Thoracic Cancer, Vol.13, No.21, 2978-2984, 2022.
(徳島大学機関リポジトリ: 118615,   DOI: 10.1111/1759-7714.14645,   PubMed: 36106507)
16. Yasuhiko Nishioka, Yuko Toyoda, Ryoko Egashira, Takeshi Johkoh, Yasuhiro Terasaki, Akira Hebisawa, Kinya Abe, Tomohisa Baba, Yuji Fujikura, Etsuo Fujita, Naoki Hamada, Tomohiro Handa, Yoshinori Hasegawa, Koko Hidaka, Takeshi Hisada, Shu Hisata, Chisato Honjo, Kazuya Ichikado, Yoshikazu Inoue, Shinyu Izumi, Motoyasu Kato, Takumi Kishimoto, Masaki Okamoto, Keisuke Miki, Masamichi Mineshita, Yutaro Nakamura, Susumu Sakamoto, Masaaki Sano, Yoshikazu Tsukada, Mari Yamasue, Yoshimi Bando, Sakae Homma, Koichi Hagiwara, Takafumi Suda and Naohiko Inase :
Nationwide retrospective observational study of idiopathic dendriform pulmonary ossification: clinical features with a progressive phenotype.,
BMJ Open Respiratory Research, Vol.9, No.1, e001337, 2022.
(徳島大学機関リポジトリ: 118569,   DOI: 10.1136/bmjresp-2022-001337,   PubMed: 36162917)
17. Masaki Hanibuchi, Atsuro Saijo, Atsushi Mitsuhashi, Tatsuya Kajimoto, Tetsuya Kitagawa and Yasuhiko Nishioka :
The efficacy of mass screening for chronic obstructive pulmonary disease using screening questionnaires in a medical health check-up population.,
Respiratory Investigation, Vol.60, No.6, 815-821, 2022.
(DOI: 10.1016/j.resinv.2022.07.005,   PubMed: 36057534)
18. Takashi Ogura, Takafumi Suda, Naohiko Inase, Yasuhiko Nishioka, Arata Azuma, Masaki Okamoto, Ayako Takizawa, Tomohiro Ito, B Klaus Rohr and Yoshikazu Inoue :
Effects of nintedanib on disease progression and safety in Japanese patients with progressive fibrosing interstitial lung diseases: Further subset analysis from the whole INBUILD trial.,
Respiratory Investigation, Vol.60, No.6, 787-797, 2022.
(DOI: 10.1016/j.resinv.2022.06.009,   PubMed: 35927208)
19. Yoshitoyo Ueno, Saki Harada, Koji Sato, Kazuki Momota, Hiroki Sato, Yusuke Akimoto, Yuta Arai, Toshiyuki Nunomura, Manabu Ishihara, Natsuki Tane, Taiga Itagaki, Yasuhiko Nishioka and Jun Oto :
Independent lung ventilation for the management of acute allograft rejection after single-lung transplantation for end-stage emphysema.,
The Journal of Medical Investigation : JMI, Vol.69, No.3.4, 323-327, 2022.
(DOI: 10.2152/jmi.69.323,   PubMed: 36244790)
20. Eiji Takeuchi, Kensuke Kondo, Yoshio Okano, Michihiro Kunishige, Yoshihiro Kondo, Naoki Kadota, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Hirokazu Ogino, Hiroshi Nokihara, Tsutomu Shinohara and Yasuhiko Nishioka :
Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer.,
Journal of Cancer Research and Clinical Oncology, 2022.
(徳島大学機関リポジトリ: 118880,   DOI: 10.1007/s00432-022-04215-7,   PubMed: 35871700)
21. Takumi Sakurada, Hiroshi Nokihara, Tadashi Koga, Yoshito Zamami, Mitsuhiro Goda, Kenta Yagi, Hirofumi Hamano, Fuka Aizawa, Hirokazu Ogino, Seidai Satou, Yasushi Kirino, Hisatsugu Goto, Yasuhiko Nishioka and Keisuke Ishizawa :
Prevention of Pemetrexed-Induced Rash Using Low-Dose Corticosteroids: A Phase II Study.,
The Oncologist, Vol.27, No.7, e554-e560, 2022.
(徳島大学機関リポジトリ: 117391,   DOI: 10.1093/oncolo/oyab077,   PubMed: 35325241)
22. Hiroshi Nokihara, Hirokazu Ogino, Atsushi Mitsuhashi, Kensuke Kondo, Ei Ogawa, Ryohiko Ozaki, Yohei Yabuki, Hiroto Yoneda, Kenji Otsuka and Yasuhiko Nishioka :
Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion.,
BMC Cancer, Vol.22, No.1, 2022.
(徳島大学機関リポジトリ: 117282,   DOI: 10.1186/s12885-022-09701-2,   PubMed: 35650550)
23. Jun Kako, Masamitsu Kobayashi, Kohei Kajiwara, Yasutaka Kimura, Yasufumi Oosono, Mizuki Takegata, Kimiko Nakano, Yoshinobu Matsuda, Naomi Nakamura, Natsuki Kawashima, Yuta Hirano, Misako Kitae, Kakuhiro Yamaguchi, Hiroshi Iwamoto, Noboru Hattori, Hiroyuki Sawatari, Satoshi Shiono, Hirokazu Ogino, Yasuhiko Nishioka, Koji Amano and Janelle Yorke :
Validity and Reliability of the Japanese Version of the Dyspnea-12 Questionnaire in Patients With Lung Cancer.,
Journal of Pain and Symptom Management, Vol.64, No.2, e83-e89, 2022.
(DOI: 10.1016/j.jpainsymman.2022.04.171,   PubMed: 35452793)
24. Hitoshi Nishijima, Mizuki Sugita, Natsuka Umezawa, Naoki Kimura, Hirokazu Sasaki, Hiroshi Kawano, Yasuhiko Nishioka, Minoru Matsumoto, Takeshi Oya, Koichi Tsuneyama, Junko Morimoto and Mitsuru Matsumoto :
Development of organ-specific autoimmunity by dysregulated Aire expression.,
Immunology and Cell Biology, Vol.100, No.5, 371-377, 2022.
(徳島大学機関リポジトリ: 117817,   DOI: 10.1111/imcb.12546,   PubMed: 35313042)
25. Hirohisa Ogawa, Masahiko Azuma, Aya Umeno, Mayuko Shimizu, Kazutoshi Murotomi, Yasukazu Yoshida, Yasuhiko Nishioka and Koichi Tsuneyama :
Singlet oxygen -derived nerve growth factor exacerbates airway hyperresponsiveness in a mouse model of asthma with mixed inflammation.,
Allergology International, Vol.71, No.3, 395-404, 2022.
(徳島大学機関リポジトリ: 117273,   DOI: 10.1016/j.alit.2022.02.005,   PubMed: 35346582)
26. Hirokazu Ogino, W Jennie Taylor, Takahide Nejo, David Gibson, B Payal Watchmaker, Kaori Okada, Atsuro Saijo, R Meghan Tedesco, Anny Shai, M Cynthia Wong, E Jane Rabbitt, R Michael Olin, L Christopher Moertel, Yasuhiko Nishioka, M Andres Salazar, M Annette Molinaro, J Joanna Phillips, A Nicholas Butowski, L Jennifer Clarke, Ann Bush Nancy Oberheim, L Shawn Hervey-Jumper, Philip Theodosopoulos, M Susan Chang, S Mitchel Berger and Hideho Okada :
Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas.,
The Journal of Clinical Investigation, Vol.132, No.3, 2022.
(徳島大学機関リポジトリ: 117337,   DOI: 10.1172/JCI151239,   PubMed: 34882581)
27. Yutaka Morita, Atsuro Saijo, Hiroshi Nokihara, Atsushi Mitsuhashi, Hiroto Yoneda, Kenji Otsuka, Hirokazu Ogino, Yoshimi Bando and Yasuhiko Nishioka :
Radiation therapy induces an abscopal effect and upregulates programmed death-ligand 1 expression in a patient with non-small cell lung cancer.,
Thoracic Cancer, Vol.13, No.7, 1079-1082, 2022.
(徳島大学機関リポジトリ: 117392,   DOI: 10.1111/1759-7714.14330,   PubMed: 35064748)
28. Tamotsu Tanaka, Kazuya Koyama, Naoko Takahashi, Katsuya Morito, Hanif Ali, Momoyo Azuma, Kozo Kagawa, Hiroshi Kawano, Rumana Yesmin, Mutsumi Aihara and Yasuhiko Nishioka :
Lysophosphatidic acid, ceramide 1-phosphate and sphingosine 1-phosphate in peripheral blood of patients with idiophathic pulmonary fibrosis,
The Journal of Medical Investigation : JMI, Vol.69, No.3.4, 196-203, 2022.
(徳島大学機関リポジトリ: 117621,   DOI: 10.2152/jmi.69.196,   PubMed: 36244770)
29. Masahiro Sako, Hiroshi Nokihara, Kensuke Kondo, Atsushi Mitsuhashi, Ryohiko Ozaki, Yohei Yabuki, Akane Abe, Hiroto Yoneda, Hirokazu Ogino, Kenji Otsuka, Hisanori Uehara and Yasuhiko Nishioka :
A case of pulmonary pleomorphic carcinoma with preexisting interstitial pneumonia successfully treated with pembrolizumab.,
Thoracic Cancer, Vol.13, No.1, 129-132, 2021.
(徳島大学機関リポジトリ: 117393,   DOI: 10.1111/1759-7714.14243,   PubMed: 34859591)
30. Hiroto Yoneda, Hiroshi Nokihara, Atsushi Mitsuhashi, Ryohiko Ozaki, Yohei Yabuki, Hirokazu Ogino, Kenji Otsuka and Yasuhiko Nishioka :
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma.,
BMC Pulmonary Medicine, Vol.21, No.1, 2021.
(徳島大学機関リポジトリ: 117283,   DOI: 10.1186/s12890-021-01746-6,   PubMed: 34781910)
31. Toshifumi Tezuka, Masahiko Azuma, Hirohisa Ogawa, Mayo Kondou, Hisanori Uehara, Yoshinori Aono, Masaki Hanibuchi and Yasuhiko Nishioka :
A RAS inhibitor reduces allergic airway remodeling via regulating IL-33-derived type 2 innate lymphoid cells.,
Experimental Lung Research, Vol.47, No.9, 451-463, 2021.
(DOI: 10.1080/01902148.2021.1999536,   PubMed: 34739349)
32. Atsushi Mitsuhashi, Kensuke Kondoh, Kazuki Horikawa, Kazuya Koyama, Thi Na Nguyen, Tania Afroj, Hiroto Yoneda, Kenji Otsuka, Hirokazu Ogino, Hiroshi Nokihara, Tsutomu Shinohara and Yasuhiko Nishioka :
Programmed death (PD)-1/PD-ligand 1 blockade mediates antiangiogenic effects by tumor-derived CXCL10/11 as a potential predictive biomarker.,
Cancer Science, Vol.112, No.12, 4853-4866, 2021.
(徳島大学機関リポジトリ: 117305,   DOI: 10.1111/cas.15161,   PubMed: 34628702)
33. Hirokazu Ogino, Makoto Tobiume, Kozo Kagawa, Hiroshi Kawano, Satoshi Sakaguchi, Atsuro Saijo, Daisuke Matsumoto, Hiromitsu Takizawa, Yuriko Morikawa, Yoshimi Bando, Hisatsugu Goto, Hiroshi Nokihara and Yasuhiko Nishioka :
A Case of Radiation-associated Angiosarcoma Presenting as Massive Pleural Effusion.,
Internal Medicine, Vol.61, No.9, 1393-1397, 2021.
(徳島大学機関リポジトリ: 118013,   DOI: 10.2169/internalmedicine.8195-21,   PubMed: 34645765)
34. Yasuhiro Kondoh, Shigeki Makino, Takashi Ogura, Takafumi Suda, Hiromi Tomioka, Hirofumi Amano, Masaki Anraku, Noriyuki Enomoto, Takao Fujii, Tomoyuki Fujisawa, Takahisa Gono, Masayoshi Harigai, Hidenori Ichiyasu, Yoshikazu Inoue, Takeshi Johkoh, Hideto Kameda, Kensuke Kataoka, Yasuhiro Katsumata, Yasushi Kawaguchi, Atsushi Kawakami, Hideya Kitamura, Noboru Kitamura, Tomohiro Koga, Kazuhiro Kurasawa, Yutaro Nakamura, Ran Nakashima, Yasuhiko Nishioka, Osamu Nishiyama, Masaki Okamoto, Fumikazu Sakai, Susumu Sakamoto, Shinji Sato, Toshimasa Shimizu, Noboru Takayanagi, Reoto Takei, Tamiko Takemura, Tohru Takeuchi, Yuko Toyoda, Hidehiro Yamada, Hideaki Yamakawa, Yasuhiko Yamano, Yoshioki Yamasaki and Masataka Kuwana :
2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease.,
Respiratory Investigation, Vol.59, No.6, 709-740, 2021.
(DOI: 10.1016/j.resinv.2021.04.011,   PubMed: 34602377)
35. Takeshi Imakura, Seidai Satou, Tetsu Tomonari, Kojin Murakami, Naoki Takahashi, Nobuhito Naito, Masato Mima, Kozo Kagawa, Kazuya Koyama, Haruka Nishimura, Hiroshi Kawano, Hiroshi Nokihara, Masahiko Azuma, Tetsuji Takayama and Yasuhiko Nishioka :
Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma.,
Internal Medicine, Vol.61, No.8, 1211-1217, 2021.
(徳島大学機関リポジトリ: 118011,   DOI: 10.2169/internalmedicine.7300-21,   PubMed: 34544944)
36. Yasuhiko Nishioka, Sakae Homma, Takahito Okubo and Arata Azuma :
Design of phase 2 study of TAS-115, a novel oral multi-kinase inhibitor, in patients with idiopathic pulmonary fibrosis.,
Contemporary Clinical Trials Communications, Vol.23, 2021.
(DOI: 10.1016/j.conctc.2021.100832,   PubMed: 34471721)
37. Yoshikazu Inoue, Takafumi Suda, Hideya Kitamura, Masaki Okamoto, Arata Azuma, Naohiko Inase, Masataka Kuwana, Shigeki Makino, Yasuhiko Nishioka, Takashi Ogura, Ayako Takizawa, Hiroyuki Ugai, Susanne Stowasser, Rozsa Schlenker-Herceg and Tsutomu Takeuchi :
Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial.,
Respiratory Medicine, Vol.187, 2021.
(徳島大学機関リポジトリ: 117384,   DOI: 10.1016/j.rmed.2021.106574,   PubMed: 34564020)
38. Takuma Isshiki, Sakae Homma, Yoshinobu Eishi, Matsuko Yabe, Kazuya Koyama, Yasuhiko Nishioka, Tetsuo Yamaguchi, Keisuke Uchida, Kurara Yamamoto, Kenichi Ohashi, Atsushi Arakawa, Kazutoshi Shibuya, Susumu Sakamoto and Kazuma Kishi :
Usefulness of imunohistochemical detection of Propionibacterium acnes in granulomas for differentiating sarcoidosis from other garanulomatous diseases; comparison between manual and automated immunohistochemical detection methods.,
Microorganisms, Vol.9, No.8, 2021.
(徳島大学機関リポジトリ: 117354,   DOI: 10.3390/microorganisms9081668,   PubMed: 34442747)
39. Noriyuki Enomoto, Sakae Homma, Naohiko Inase, Yasuhiro Kondoh, Takeshi Saraya, Hajime Takizawa, Yoshikazu Inoue, Hiroshi Ishii, Yoshio Taguchi, Shinyu Izumi, Yasuhiko Yamano, Yoshinori Tanino, Yasuhiko Nishioka, Mikio Toyoshima, Koshi Yokomura, Shiro Imokawa, Naoki Koshimizu, Takehisa Sano, Taisuke Akamatsu, Hiroshi Mukae, Motoyasu Kato, Naoki Hamada, Hirofumi Chiba, Shinobu Akagawa, Shigeo Muro, Hironori Uruga, Hiroyuki Matsuda, Yusuke Kaida, Miho Kanai, Kazutaka Mori, Masafumi Masuda, Hironao Hozumi, Tomoyuki Fujisawa, Yutaro Nakamura, Noriyoshi Ogawa and Takafumi Suda :
Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias.,
Thorax, Vol.77, No.2, 143-153, 2021.
(DOI: 10.1136/thoraxjnl-2020-216263,   PubMed: 34272335)
40. Keiko Haji, Seidai Satou, Hiroto Yoneda, Toshihiko Nisisho, Hiroshi Nokihara and Yasuhiko Nishioka :
Multidisciplinary treatment of skeletal muscle metastasis from lung cancer: A case of triceps muscle metastasis of lung squamous cell cancer.,
Respiratory Medicine Case Reports, Vol.33, 2021.
(徳島大学機関リポジトリ: 117385,   DOI: 10.1016/j.rmcr.2021.101470,   PubMed: 34401306)
41. Fumie Nakasuka, Sho Tabata, Takeharu Sakamoto, Akiyoshi Hirayama, Hiromichi Ebi, Tadaaki Yamada, Ko Umetsu, Maki Ohishi, Ayano Ueno, Hisatsugu Goto, Masahiro Sugimoto, Yasuhiko Nishioka, Yasuhiro Yamada, Masaru Tomita, T Atsuo Sasaki, Seiji Yano and Tomoyoshi Soga :
TGF-β-dependent reprogramming of amino acid metabolism induces epithelial-mesenchymal transition in non-small cell lung cancers.,
Communications Biology, Vol.4, No.1, 2021.
(徳島大学機関リポジトリ: 116517,   DOI: 10.1038/s42003-021-02323-7,   PubMed: 34168290)
42. Shu Hisata, Masashi Bando, Sakae Homma, Kensuke Kataoka, Takashi Ogura, Shinyu Izumi, Susumu Sakamoto, Kizuku Watanabe, Yoshinobu Saito, Yasuo Shimizu, Motoyasu Kato, Yasuhiko Nishioka, Hiromichi Hara, Yuko Waseda, Yoshinori Tanino, Kazuhiro Yatera, Seishu Hashimoto, Hiroshi Mukae and Naohiko Inase :
Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A multicenter retrospective observational study in Japan.,
Respiratory Investigation, Vol.59, No.6, 819-826, 2021.
(DOI: 10.1016/j.resinv.2021.04.005,   PubMed: 33994347)
43. Seidai Satou, Giin Sy Chong, Chandak Upagupta, Toyoshi Yanagihara, Takuya Saito, Chiko Shimbori, Pierre-Simon Bellaye, Yasuhiko Nishioka and Rj Martin Kolb :
Fibrotic extracellular matrix induces release of extracellular vesicles with pro-fibrotic miRNA from fibrocytes.,
Thorax, Vol.76, No.9, 895-906, 2021.
(DOI: 10.1136/thoraxjnl-2020-215962,   PubMed: 33859055)
44. Hiroshi Mukae, Takeshi Kaneko, Yasushi Obase, Masaharu Shinkai, Toshio Katsunuma, Kiyoshi Takeyama, Jiro Terada, Akio Niimi, Hiroto Matsuse, Kazuhiro Yatera, Yoshihiro Yamamoto, Arata Azuma, Hirokazu Arakawa, Takashi Iwanaga, Haruhiko Ogawa, Kiyoyasu Kurahashi, Yasuhiro Gon, Hirokazu Sakamoto, Yoko Shibata, Tsutomu Tamada, Yasuhiko Nishioka, Shusaku Haranaga, Shigeharu Fujieda, Naoyuki Miyashita, Hiroyuki Mochizuki, Akihito Yokoyama, Shigemi Yoshihara and Jun Tamaoki :
The Japanese respiratory society guidelines for the management of cough and sputum (digest edition).,
Respiratory Investigation, Vol.59, No.3, 270-290, 2021.
(DOI: 10.1016/j.resinv.2021.01.007,   PubMed: 33642231)
45. Tania Afroj, Atsushi Mitsuhashi, Hirokazu Ogino, Atsuro Saijo, Kenji Otsuka, Hiroto Yoneda, Makoto Tobiume, Thi Na Nguyen, Hisatsugu Goto, Kazuya Koyama, Masamichi Sugimoto, Osamu Kondoh, Hiroshi Nokihara and Yasuhiko Nishioka :
Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.,
The Journal of Immunology, Vol.206, No.6, 1204-1214, 2021.
(徳島大学機関リポジトリ: 115981,   DOI: 10.4049/jimmunol.2000909,   PubMed: 33504617)
46. Susumu Sakamoto, Kensuke Kataoka, Yasuhiro Kondoh, Motoyasu Kato, Masaki Okamoto, Hiroshi Mukae, Masashi Bando, Takafumi Suda, Kazuhiro Yatera, Yoshinori Tanino, Tomoo Kishaba, Noboru Hattori, Yoshio Taguchi, Takefumi Saito, Yasuhiko Nishioka, Kazuyoshi Kuwano, Kazuma Kishi, Naohiko Inase, Shinichi Sasaki, Hajime Takizawa, Takeshi Johkoh, Fumikazu Sakai and Sakae Homma :
Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial.,
The European Respiratory Journal, Vol.57, No.1, 2021.
(DOI: 10.1183/13993003.00348-2020,   PubMed: 32703779)
47. Hiroshi Kawano, Kazuya Koyama, Haruka Nishimura, Yuko Toyoda, Kozo Kagawa, Seidai Satou, Nobuhito Naito, Hisatsugu Goto, Yutaka Inagaki and Yasuhiko Nishioka :
Development of improved method to identify and analyze lung fibrocytes with flow cytometry in a reporter mouse strain.,
Immunity, Inflammation and Disease, Vol.9, No.1, 120-127, 2020.
(徳島大学機関リポジトリ: 116531,   DOI: 10.1002/iid3.361,   PubMed: 33369271)
48. Nobuhito Naito, Hiroshi Kawano, Yuya Yamashita, Mayo Kondou, Shotaro Haji, Ryosuke Miyamoto, Yuko Toyoda, Yasuhisa Kanematsu, Yuishin Izumi, Yoshimi Bando and Yasuhiko Nishioka :
Neuropsychiatric systemic lupus erythematosus with cerebellar vasculitis and obstructive hydrocephalus requiring decompressive craniectomy.,
Modern Rheumatology Case Reports, Vol.5, No.1, 52-57, 2020.
(DOI: 10.1080/24725625.2020.1826626,   PubMed: 33021438)
49. Momoyo Azuma, Keiji Murakami, Rina Murata, Keiko Kataoka, Hideki Fujii, Yoichiro Miyake and Yasuhiko Nishioka :
Clinical Significance of Carbapenem-Tolerant Pseudomonas aeruginosa Isolated in the Respiratory Tract,
Antibiotics, Vol.9, No.9, 2020.
(徳島大学機関リポジトリ: 116480,   DOI: 10.3390/antibiotics9090626,   PubMed: 32967210)
50. Shun Morizumi, Seidai Satou, Kazuya Koyama, Hiroyasu Okazaki, Yajuan Chen, Hisatsugu Goto, Kozo Kagawa, Hirohisa Ogawa, Haruka Nishimura, Hiroshi Kawano, Yuko Toyoda, Hisanori Uehara and Yasuhiko Nishioka :
Blockade of Pan-Fibroblast Growth Factor Receptors Mediates Bidirectional Effects in Lung Fibrosis.,
American Journal of Respiratory Cell and Molecular Biology, Vol.63, No.3, 317-326, 2020.
(徳島大学機関リポジトリ: 115073,   DOI: 10.1165/rcmb.2019-0090OC,   PubMed: 32338990)
51. Mayo Kondou, Toshifumi Tezuka, Hirohisa Ogawa, Kazuya Koyama, Hiroki Bando, Masahiko Azuma and Yasuhiko Nishioka :
Lysophosphatidic Acid Regulates the Differentiation of Th2 Cells and Its Antagonist Suppresses Allergic Airway Inflammation.,
International Archives of Allergy and Immunology, Vol.182, No.1, 1-13, 2020.
(徳島大学機関リポジトリ: 115394,   DOI: 10.1159/000509804,   PubMed: 32846422)
52. Naoto Okada, Rie Matsuoka, Takumi Sakurada, Mitsuhiro Goda, Masayuki Chuma, Kenta Yagi, Yoshito Zamami, Yasuhiko Nishioka and Keisuke Ishizawa :
Risk factors of immune checkpoint inhibitor-related interstitial lung disease in patients with lung cancer: a single-institution retrospective study.,
Scientific Reports, Vol.10, No.1, 2020.
(徳島大学機関リポジトリ: 116635,   DOI: 10.1038/s41598-020-70743-2,   PubMed: 32792640)
53. Sakae Homma, Masahito Ebina, Kazuyoshi Kuwano, Hisatsugu Goto, Fumikazu Sakai, Susumu Sakamoto, Takeshi Johkoh, Keishi Sugino, Teruo Tachibana, Yasahiro Terasaki, Yasuhiko Nishioka, Koichi Hagiwara, Naozumi Hashimoto, Yoshinori Hasegawa and Akira Hebisawa :
Intractable diffuse pulmonary diseases: Manual for diagnosis and treatment.,
Respiratory Investigation, Vol.59, No.1, 8-33, 2020.
(DOI: 10.1016/j.resinv.2020.04.004,   PubMed: 32622842)
54. Yuji Minegishi, Akihiko Gemma, Sakae Homma, Kazuma Kishi, Arata Azuma, Takashi Ogura, Naoki Hamada, Hiroyuki Taniguchi, Noboru Hattori, Yasuhiko Nishioka, Kiminobu Tanizawa, Takeshi Johkoh, Takuma Yokoyama, Kazutaka Mori, Yoshio Taguchi, Masahito Ebina, Naohiko Inase, Koichi Hagiwara, Hiroshi Ohnishi, Hiroshi Mukae, Yoshikazu Inoue, Kazuyoshi Kuwano, Hirofumi Chiba, Ken Ohta, Yoshinori Tanino, Fumikazu Sakai and Yukihiko Sugiyama :
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan.,
ERJ Open Research, Vol.6, No.2, 2020.
(DOI: 10.1183/23120541.00184-2019,   PubMed: 32494570)
55. Kenji Otsuka, Atsushi Mitsuhashi, Hisatsugu Goto, Masaki Hanibuchi, Kazuya Koyama, Hirohisa Ogawa, Hirokazu Ogino, Atsuro Saijo, Hiroyuki Kozai, Hiroto Yoneda, Makoto Tobiume, Masatoshi Kishuku, Keisuke Ishizawa and Yasuhiko Nishioka :
Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells.,
Lung Cancer, Vol.146, 86-96, 2020.
(徳島大学機関リポジトリ: 115324,   DOI: 10.1016/j.lungcan.2020.05.023,   PubMed: 32526602)
56. 福家 麻美, 荻野 広和, 坪井 未希, 近藤 真代, 香川 耕造, 埴淵 昌毅, 山﨑 博輝, 宮本 亮介, 豊田 優子, 西岡 安彦 :
エタンブトールによる脱髄性末梢神経障害により急速進行性の歩行障害を呈した結核性胸膜炎の1例,
日本結核・非結核性抗酸菌症学会, Vol.95, No.2, 73-77, 2020年.
57. Shuichi Abe, Seidai Satou, Yoshinori Aono, Momoyo Azuma, Masami Kishi, Koyama Kazuya, Takahashi Naoki, Kozo Kagawa, Hiroshi Kawano and Yasuhiko Nishioka :
Functional analysis of human fibrocytes derived from monocytes reveals their profibrotic phenotype through paracrine effects,
The Journal of Medical Investigation : JMI, Vol.67, No.1.2, 102-112, 2020.
(徳島大学機関リポジトリ: 114734,   DOI: 10.2152/jmi.67.102,   PubMed: 32378592)
58. Takeshi Imakura, Yuko Toyoda, Seidai Satou, Kazuya Koyama, Haruka Nishimura, Kozo Kagawa, Naoki Takahashi, Nobuhito Naito, Kojin Murakami, Hiroshi Kawano, Masahiko Azuma, Tsutomu Shinohara and Yasuhiko Nishioka :
Distinct improvement of pulmonary function, ground-glass opacity, hypoxia and physical findings in an idiopathic pulmonary fibrosis patient after pirfenidone treatment : a case report with a review of the literature.,
The Journal of Medical Investigation : JMI, Vol.67, No.3.4, 358-361, 2020.
(徳島大学機関リポジトリ: 115454,   DOI: 10.2152/jmi.67.358,   PubMed: 33148916)
59. Akio Takezaki, Shin-ichi Tsukumo, Yasuhiro Setoguchi, G Julie Ledford, Hisatsugu Goto, Kazuyoshi Hosomichi, Hisanori Uehara, Yasuhiko Nishioka and Koji Yasutomo :
A homozygous SFTPA1 mutation drives necroptosis of type II alveolar epithelial cells in patients with idiopathic pulmonary fibrosis.,
The Journal of Experimental Medicine, Vol.216, No.12, 2724-2735, 2019.
(徳島大学機関リポジトリ: 114694,   DOI: 10.1084/jem.20182351,   PubMed: 31601679)
60. Takashi Ogura, Nagio Takigawa, Keisuke Tomii, Kazuma Kishi, Yoshikazu Inoue, Eiki Ichihara, Sakae Homma, Kazuhisa Takahashi, Hiroaki Akamatsu, Satoshi Ikeda, Naohiko Inase, Tae Iwasawa, Yuichiro Ohe, Hiromitsu Ohta, Hiroshi Onishi, Isamu Okamoto, Kazumasa Ogawa, Kazuo Kasahara, Hiroki Karata, Takumi Kishimoto, Yuka Kitamura, Akihiko Gemma, Hirotsugu Kenmotsu, Hiroyuki Sakashita, Susumu Sakamoto, Katsutoshi Sekine, Yuichi Takiguchi, Yuji Tada, Shinichi Toyooka, Yuko Nakayama, Yasuhiko Nishioka, Koichi Hagiwara, Masaki Hanibuchi, Junya Fukuoka, Yuji Minegishi, Toyoshi Yanagihara, Nobuyuki Yamamoto, Hiromasa Yamamoto, Mina Gaga, M Kwun Fong, A Charles Powell and Katsuyuki Kiura :
Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia.,
Respiratory Investigation, Vol.57, No.6, 512-533, 2019.
(DOI: 10.1016/j.resinv.2019.06.001,   PubMed: 31377122)
61. Akihiro Yoshimura, Tadaaki Yamada, Yusuke Okuma, Rui Kitadai, Takayuki Takeda, Takanori Kanematsu, Hisatsugu Goto, Hiroto Yoneda, Taishi Harada, Yutaka Kubota, Takahiro Yamada, Koji Date, Shinsuke Shiotsu, Kazuhiro Nagata, Yusuke Chihara, Yoshiko Kaneko, Junji Uchino, Yasuhiko Nishioka and Koichi Takayama :
Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients.,
Translational Lung Cancer Research, Vol.8, No.4, 450-460, 2019.
(徳島大学機関リポジトリ: 116474,   DOI: 10.21037/tlcr.2019.08.07,   PubMed: 31555518)
62. M Toby Maher, Susanne Stowasser, Yasuhiko Nishioka, S Eric White, Vincent Cottin, Imre Noth, Moisés Selman, B Klaus Rohr, Andreas Michael, Carina Ittrich, Claudia Diefenbach and Gisli R Jenkins :
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study.,
The Lancet. Respiratory Medicine, Vol.7, No.9, 771-779, 2019.
(DOI: 10.1016/S2213-2600(19)30255-3,   PubMed: 31326319)
63. Hiroyasu Okazaki, Seidai Satou, Kazuya Koyama, Shun Morizumi, Shuichi Abe, Momoyo Azuma, Yajuan Chen, Hisatsugu Goto, Yoshinori Aono, Hirohisa Ogawa, Kozo Kagawa, Haruka Nishimura, Hiroshi Kawano, Yuko Toyoda, Hisanori Uehara, Hiroyuki Kouji and Yasuhiko Nishioka :
The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.,
Experimental Lung Research, Vol.45, No.7, 188-199, 2019.
(徳島大学機関リポジトリ: 113984,   DOI: 10.1080/01902148.2019.1638466,   PubMed: 31298961,   Elsevier: Scopus)
64. Yuko Toyoda, Kazuya Koyama, Hiroshi Kawano, Haruka Nishimura, Kozo Kagawa, Shun Morizumi, Nobuhito Naito, Seidai Satou, Yuya Yamashita, Naoki Takahashi, Hisatsugu Goto, Masahiko Azuma and Yasuhiko Nishioka :
Clinical features of interstitial pneumonia associated with systemic lupus erythematosus.,
Respiratory Investigation, Vol.57, No.5, 435-443, 2019.
(DOI: 10.1016/j.resinv.2019.04.005,   PubMed: 31235450)
65. Masaki Hanibuchi, Akira Kanoh, Takuya Kuramoto, Tatsuro Saito, Makoto Tobiume, Atsuro Saijo, Hiroyuki Kozai, Mayo Kondou, Shun Morizumi, Hiroto Yoneda, Kozo Kagawa, Hirokazu Ogino, Seidai Satou, Hiroshi Kawano, Kenji Otsuka, Yuko Toyoda, Hiroshi Nokihara, Hisatsugu Goto and Yasuhiko Nishioka :
Development, validation, and comparison of gene analysis methods for detecting mutation from non-small cell lung cancer patients-derived circulating free DNA.,
Oncotarget, Vol.10, No.38, 3654-3666, 2019.
(徳島大学機関リポジトリ: 115668,   DOI: 10.18632/oncotarget.26951,   PubMed: 31217900)
66. Kazuya Koyama, Hisatsugu Goto, Shun Morizumi, Kozo Kagawa, Haruka Nishimura, Seidai Satou, Hiroshi Kawano, Yuko Toyoda, Hirohisa Ogawa, Sakae Homma and Yasuhiko Nishioka :
The Tyrosine Kinase Inhibitor TAS-115 Attenuates Bleomycin-induced Lung Fibrosis in Mice.,
American Journal of Respiratory Cell and Molecular Biology, Vol.60, No.4, 478-487, 2019.
(DOI: 10.1165/rcmb.2018-0098OC,   PubMed: 30540913)
67. Atsuro Saijo, Masaki Hanibuchi, Hirokazu Ogino, Kenji Otsuka, Hisatsugu Goto, Hiroshi Nokihara and Yasuhiko Nishioka :
Paclitaxel for relapsed small-cell lung cancer patients with idiopathic interstitial pneumonias.,
Molecular and Clinical Oncology, Vol.10, No.5, 541-546, 2019.
(DOI: 10.3892/mco.2019.1828,   PubMed: 30967948)
68. Taichi Murakami, Masanori Tamaki, Seiji Kishi, Kojiro Nagai, Hideharu Abe, Yoshimi Bando, Yuko Toyoda, Hirokazu Ogino, Yasuhiko Nishioka, Sayo Ueda, Toshio Doi and Motokazu Matsuura :
Systemic Sarcoidosis Presenting with Renal Involvement Caused by Various Sarcoidosis-associated Pathophysiological Conditions,
Internal Medicine, Vol.58, No.5, 679-684, 2019.
(徳島大学機関リポジトリ: 114405,   DOI: 10.2169/internalmedicine.1558-18,   PubMed: 30449791,   Elsevier: Scopus)
69. Hirokazu Ogino, Masaki Hanibuchi, Satoshi Sakaguchi, Yuko Toyoda, Toshifumi Tezuka, Hiroshi Kawano, Soji Kakiuchi, Kenji Otsuka, Atsuro Saijo, Masahiko Azuma, Hiroshi Nokihara, Hisatsugu Goto and Yasuhiko Nishioka :
The clinical features of older patients with lung cancer in comparison with their younger counterparts.,
Respiratory Investigation, Vol.57, No.1, 40-48, 2019.
(DOI: 10.1016/j.resinv.2018.10.003,   PubMed: 30448243)
70. Masami Kishi, Yoshinori Aono, Seidai Satou, Kazuya Koyama, Momoyo Azuma, Shuichi Abe, Hiroshi Kawano, Jun Kishi, Yuko Toyoda, Hiroyasu Okazaki, Hirohisa Ogawa, Hisanori Uehara and Yasuhiko Nishioka :
Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice.,
PLoS ONE, Vol.13, No.12, 2018.
(徳島大学機関リポジトリ: 113268,   DOI: 10.1371/journal.pone.0209786,   PubMed: 30596712)
71. Hirohisa Ogawa, Masahiko Azuma, Takaaki Tsunematsu, Yuuki Morimoto, Mayo Kondo, Toshifumi Tezuka, Yasuhiko Nishioka and Koichi Tsuneyama :
Neutrophils induce smooth muscle hyperplasia via neutrophil elastase-induced FGF-2 in a mouse model of asthma with mixed inflammation.,
Clinical and Experimental Allergy, Vol.48, No.12, 1715-1725, 2018.
(DOI: 10.1111/cea.13263,   PubMed: 30171733)
72. Masaki Hanibuchi, Soji Kakiuchi, Shinji Atagi, Fumitaka Ogushi, Eiji Shimizu, Takashi Haku, Yuko Toyoda, Masahiko Azuma, Mayo Kondo, Hiroshi Kawano, Kenji Otsuka, Satoshi Sakaguchi, Hiroshi Nokihara, Hisatsugu Goto and Yasuhiko Nishioka :
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease.,
Lung Cancer, Vol.125, 93-99, 2018.
(DOI: 10.1016/j.lungcan.2018.09.007,   PubMed: 30429044)
73. M Toby Maher, Susanne Stowasser, Yasuhiko Nishioka, S Eric White, Vincent Cottin, Imre Noth, Moisés Selman, Zuzana Blahova, Daniel Wachtlin, Claudia Diefenbach and Gisli R Jenkins :
Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial.,
BMJ Open Respiratory Research, Vol.5, No.1, e000325, 2018.
(徳島大学機関リポジトリ: 114353,   DOI: 10.1136/bmjresp-2018-000325,   PubMed: 30167310)
74. Rao Rajeswara Arasada, Konstantin Shilo, Tadaaki Yamada, Jianying Zhang, Seiji Yano, Rashelle Ghanem, Walter Wang, Shinji Takeuchi, Koji Fukuda, Nobuyuki Katakami, Keisuke Tomii, Fumitaka Ogushi, Yasuhiko Nishioka, Tiffany Talabere, Shrilekha Misra, Wenrui Duan, Paolo Fadda, A Mohammad Rahman, Patrick Nana-Sinkam, Jason Evans, Joseph Amann, E Elena Tchekneva, M Mikhail Dikov and P David Carbone :
Notch3-dependent -catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC.,
Nature Communications, Vol.9, No.1, 3198, 2018.
(徳島大学機関リポジトリ: 114785,   DOI: 10.1038/s41467-018-05626-2,   PubMed: 30097569)
75. Mayo Kondo, Hirokazu Ogino, Hirohisa Ogawa, Tania Afroj, Yuko Toyoda, Satoshi Sakaguchi, Miki Tsuboi, Yoshimi Bando, Hisatsugu Goto, Koichi Tsuneyama and Yasuhiko Nishioka :
A case of pulmonary pleomorphic carcinoma with malignant phenotypes induced by ZEB1-associated epithelial-mesenchymal transition.,
Respiratory Medicine Case Reports, Vol.25, 119-121, 2018.
(徳島大学機関リポジトリ: 115710,   DOI: 10.1016/j.rmcr.2018.07.008,   PubMed: 30112272)
76. Sakae Homma, Masashi Bando, Arata Azuma, Susumu Sakamoto, Keishi Sugino, Yoshiki Ishii, Shinyu Izumi, Naohiko Inase, Yoshikazu Inoue, Masahito Ebina, Takashi Ogura, Kazuma Kishi, Tomoo Kishaba, Takashi Kido, Akihiko Gemma, Yoshihito Goto, Shinichi Sasaki, Takeshi Johkoh, Takafumi Suda, Kazuhisa Takahashi, Hiroki Takahashi, Yoshio Taguchi, Hiroshi Date, Hiroyuki Taniguchi, Takeo Nakayama, Yasuhiko Nishioka, Yoshinori Hasegawa, Noboru Hattori, Junya Fukuoka, Atsushi Miyamoto, Hiroshi Mukae, Akihito Yokoyama, Ichiro Yoshino and Kentaro Watanabe :
Japanese guideline for the treatment of idiopathic pulmonary fibrosis.,
Respiratory Investigation, Vol.56, No.4, 268-291, 2018.
(DOI: 10.1016/j.resinv.2018.03.003,   PubMed: 29980444)
77. Seiji Kishi, Masanori Minato, Atsuro Saijo, Naoka Murakami, Masanori Tamaki, Motokazu Matsuura, Taichi Murakami, Kojiro Nagai, Hideharu Abe, Yasuhiko Nishioka and Toshio Doi :
IgA Nephropathy after Nivolumab Therapy for Postoperative Recurrence of Lung Squamous Cell Carcinoma.,
Internal Medicine, Vol.57, No.9, 1259-1263, 2018.
(徳島大学機関リポジトリ: 114399,   DOI: 10.2169/internalmedicine.9814-17,   PubMed: 29279511,   Elsevier: Scopus)
78. Atsuro Saijo, Hisatsugu Goto, Nakano Mayuri, Mitsuhashi Atsushi, Yoshinori Aono, Masaki Hanibuchi, Hirohisa Ogawa, Hisanori Uehara, Kazuya Kondo and Yasuhiko Nishioka :
Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells.,
Cancer Letters, Vol.421, 17-27, 2018.
(徳島大学機関リポジトリ: 111437,   DOI: 10.1016/j.canlet.2018.02.016,   PubMed: 29448000,   Elsevier: Scopus)
79. Sho Tabata, Masatatsu Yamamoto, Hisatsugu Goto, Akiyoshi Hirayama, Maki Ohishi, Takuya Kuramoto, Ryuji Ikeda, Misako Haraguchi, Kohichi Kawahara, Yoshinari Shinsato, Kentaro Minami, Atsuro Saijo, Yuko Toyoda, Masaki Hanibuchi, Yasuhiko Nishioka, Saburo Sone, Hiroyasu Esumi, Masaru Tomita, Tomoyoshi Soga, Tatsuhiko Furukawa and Shin-ichi Akiyama :
Thymidine catabolism promotes NADPH oxidase-derived reactive oxygen species (ROS) signalling in KB and yumoto cells.,
Scientific Reports, Vol.8, No.1, 6760, 2018.
(徳島大学機関リポジトリ: 114957,   DOI: 10.1038/s41598-018-25189-y,   PubMed: 29713062)
80. Shunsuke Itai, Tomokazu Ohishi, K Mika Kaneko, Shinji Yamada, Shinji Abe, Takuro Nakamura, Miyuki Yanaka, Yao-Wen Chang, Shun-Ichi Ohba, Yasuhiko Nishioka, Manabu Kawada, Hiroyuki Harada and Yukinari Kato :
Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.,
Oncotarget, Vol.9, No.32, 22480-22497, 2018.
(徳島大学機関リポジトリ: 113062,   DOI: 10.18632/oncotarget.25132,   PubMed: 29854293)
81. Hiroyuki Kozai, Yuko Toyoda, Hisatsugu Goto, Jun Kishi, Makoto Tobiume, Yuya Yamashita, Haruka Nishimura, Mayo Kondou, Hiroshi Kawano and Yasuhiko Nishioka :
A case of interstitial pneumonia associated with anti-PL-7 antibody in a patient with rheumatoid arthritis.,
The Journal of Medical Investigation : JMI, Vol.65, No.1,2, 147-150, 2018.
(徳島大学機関リポジトリ: 111454,   DOI: 10.2152/jmi.65.147,   PubMed: 29593187,   CiNii: 1390282679224622464,   Elsevier: Scopus)
82. Hitoshi Nishijima, Tatsuya Kajimoto, Yoshiki Matsuoka, Yasuhiro Mouri, Junko Morimoto, Minoru Matsumoto, Hiroshi Kawano, Yasuhiko Nishioka, Hisanori Uehara, Keisuke Izumi, Koichi Tsuneyama, Il-mi Okazaki, Taku Okazaki, Kazuyoshi Hosomichi, Ayako Shiraki, Makoto Shibutani, Kunitoshi Mitsumori and Mitsuru Matsumoto :
Paradoxical development of polymyositis-like autoimmunity through augmented expression of autoimmune regulator (AIRE).,
Journal of Autoimmunity, Vol.86, 75-92, 2018.
(徳島大学機関リポジトリ: 112347,   DOI: 10.1016/j.jaut.2017.09.006,   PubMed: 28931462)
83. Hisatsugu Goto, Okano Yoshio, Machida Hisanori, Hatakeyama Nobuo, Ogushi Fumitaka, Haku Takashi, Takanori Kanematsu, Tomoyuki Urata, Souji Kakiuchi, Masaki Hanibuchi, Saburo Sone and Yasuhiko Nishioka :
Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer.,
Respiratory Investigation, Vol.56, No.1, 80-86, 2018.
(DOI: 10.1016/j.resinv.2017.09.003,   PubMed: 29325686,   Elsevier: Scopus)
84. Chikugo Momoko, Sebe Mayu, Rie Tsutsumi, Iuchi Marina, Jun Kishi, Masashi Kuroda, Nagakatsu Harada, Yasuhiko Nishioka and Hiroshi Sakaue :
Effect of Janus kinase inhibition by tofacitinib on body composition and glucose metabolism.,
The Journal of Medical Investigation : JMI, Vol.65, No.3.4, 166-170, 2018.
(徳島大学機関リポジトリ: 112232,   DOI: 10.2152/jmi.65.166,   PubMed: 30282855)
85. Seidai Satou, Shinohara Shintaro, Hayashi Shinya, Morizumi Shun, Abe Shuichi, Okazaki Hiroyasu, Chen Yanjuan, Hisatsugu Goto, Yoshinori Aono, Hirohisa Ogawa, Koyama Kazuya, Nishimura Haruka, Hiroshi Kawano, Yuko Toyoda, Hisanori Uehara and Yasuhiko Nishioka :
Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity.,
Respiratory Research, Vol.18, No.1, 172, 2017.
(徳島大学機関リポジトリ: 114546,   DOI: 10.1186/s12931-017-0654-2,   PubMed: 28915889,   Elsevier: Scopus)
86. 瀧倉 輝実, 埴淵 昌毅, 豊田 優子, 近藤 真代, 香西 博之, 福家 麻美, 西岡 安彦 :
胸水中に多数のLanghans型巨細胞を認めた胸水IL-6濃度が高値であったMycobacterium avium症に伴う胸膜炎の一例,
結核, Vol.92, No.9, 559-566, 2017年.
87. Mika K Kaneko, Akiko Kunita, Shinji Yamada, Takuro Nakamura, Miyuki Yanaka, Noriko Saidoh, Yao-Wen Chang, Saori Handa, Satoshi Ogasawara, Tomokazu Ohishi, Shinji Abe, Shunsuke Itai, Hiroyuki Harada, Manabu Kawada, Yasuhiko Nishioka, Masashi Fukayama and Yukinari Kato :
Antipodocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas.,
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, Vol.36, No.4, 157-162, 2017.
(DOI: 10.1089/mab.2017.0020,   PubMed: 28665782)
88. Sho Tabata, Masatatsu Yamamoto, Hisatsugu Goto, Akiyoshi Hirayama, Maki Ohishi, Takuya Kuramoto, Atsushi Mitsuhashi, Ryuji Ikeda, Misako Haraguchi, Kohichi Kawahara, Yoshinari Shinsato, Kentaro Minami, Atsuro Saijo, Masaki Hanibuchi, Yasuhiko Nishioka, Saburo Sone, Hiroyasu Esumi, Masaru Tomita, Tomoyoshi Soga, Tatsuhiko Furukawa and Shin-ichi Akiyama :
Thymidine Catabolism as a Metabolic Strategy for Cancer Survival.,
Cell Reports, Vol.19, No.7, 1313-1321, 2017.
(徳島大学機関リポジトリ: 115054,   DOI: 10.1016/j.celrep.2017.04.061,   PubMed: 28514652)
89. K Mika Kaneko, Takuro Nakamura, Akiko Kunita, Masashi Fukayama, Shinji Abe, Yasuhiko Nishioka, Shinji Yamada, Miyuki Yanaka, Noriko Saidoh, Kanae Yoshida, Yuki Fujii, Satoshi Ogasawara and Yukinari Kato :
ChLpMab-23: Cancer-Specific Human-Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity.,
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, Vol.36, No.3, 104-112, 2017.
(DOI: 10.1089/mab.2017.0014,   PubMed: 28504613)
90. Mika K Kaneko, Shinji Yamada, Takuro Nakamura, Shinji Abe, Yasuhiko Nishioka, Akiko Kunita, Masashi Fukayama, Yuki Fujii, Satoshi Ogasawara and Yukinari Kato :
Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity.,
Cancer Medicine, Vol.6, No.4, 768-777, 2017.
(徳島大学機関リポジトリ: 115039,   DOI: 10.1002/cam4.1049,   PubMed: 28332312)
91. Mika K Kaneko, Shinji Abe, Satoshi Ogasawara, Yuki Fujii, Shinji Yamada, Takeshi Murata, Hiroaki Uchida, Hideaki Tahara, Yasuhiko Nishioka and Yukinari Kato :
Chimeric Anti-Human Podoplanin Antibody NZ-12 of Lambda Light Chain Exerts Higher Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity Compared with NZ-8 of Kappa Light Chain.,
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, Vol.36, No.1, 25-29, 2017.
(DOI: 10.1089/mab.2016.0047,   PubMed: 28157429)
92. Yukinari Kato, Akiko Kunita, Masashi Fukayama, Shinji Abe, Yasuhiko Nishioka, Hiroaki Uchida, Hideaki Tahara, Shinji Yamada, Miyuki Yanaka, Takuro Nakamura, Noriko Saidoh, Kanae Yoshida, Yuki Fujii, Ryusuke Honma, Michiaki Takagi, Satoshi Ogasawara, Takeshi Murata and K Mika Kaneko :
Antiglycopeptide Mouse Monoclonal Antibody LpMab-21 Exerts Antitumor Activity Against Human Podoplanin Through Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity.,
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, Vol.36, No.1, 20-24, 2017.
(DOI: 10.1089/mab.2016.0045,   PubMed: 28234556)
93. Mika K Kaneko, Takuro Nakamura, Ryusuke Honma, Satoshi Ogasawara, Yuki Fujii, Shinji Abe, Michiaki Takagi, Hiroyuki Harada, Hiroyoshi Suzuki, Yasuhiko Nishioka and Yukinari Kato :
Development and characterization of anti-glycopeptide monoclonal antibodies against human podoplanin, using glycan-deficient cell lines generated by CRISPR/Cas9 and TALEN.,
Cancer Medicine, Vol.6, No.2, 382-396, 2017.
(徳島大学機関リポジトリ: 115040,   DOI: 10.1002/cam4.954,   PubMed: 28101903)
94. Atsuro Saijo, Masaki Hanibuchi, Hisatsugu Goto, Yuko Toyoda, Toshifumi Tezuka and Yasuhiko Nishioka :
An analysis of the clinical features of lung cancer in patients with connective tissue diseases.,
Respiratory Investigation, Vol.55, No.2, 153-160, 2017.
(DOI: 10.1016/j.resinv.2016.11.003,   PubMed: 28274531)
95. Yoshiyuki Oyama, Noriyuki Enomoto, Yuzo Suzuki, Masato Kono, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Shigeki Kuroishi, Koshi Yokomura, Mikio Toyoshima, Shiro Imokawa, Keiji Oishi, Satoshi Watanabe, Kazuo Kasahara, Tomohisa Baba, Takashi Ogura, Hiroshi Ishii, Kentaro Watanabe, Yasuhiko Nishioka and Takafumi Suda :
Evaluation of urinary desmosines as a noninvasive diagnostic biomarker in patients with idiopathic pleuroparenchymal fibroelastosis (PPFE).,
Respiratory Medicine, Vol.123, 63-70, 2016.
(DOI: 10.1016/j.rmed.2016.12.013,   PubMed: 28137498)
96. Soji Kakiuchi, Masaki Hanibuchi, Toshifumi Tezuka, Atsuro Saijo, Kenji Otsuka, Satoshi Sakaguchi, Yuko Toyoda, Hisatsugu Goto, Hiroshi Kawano, Masahiko Azuma, Fumitaka Ogushi and Yasuhiko Nishioka :
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1.,
Respiratory Investigation, Vol.55, No.2, 145-152, 2016.
(DOI: 10.1016/j.resinv.2016.10.008,   PubMed: 28274530)
97. Yuko Toyoda, Ryohiko Ozaki, Jun Kishi, Masaki Hanibuchi, Katsuhiro Kinoshita, Toshifumi Tezuka, Hisatsugu Goto, Hiroyuki Ono, Kojiro Nagai, Yoshimi Bando, Toshio Doi and Yasuhiko Nishioka :
An Autopsy Case of Aortic Intimal Sarcoma Initially Diagnosed as Polyarteritis Nodosa.,
Internal Medicine, Vol.55, No.21, 3191-3195, 2016.
(徳島大学機関リポジトリ: 114395,   DOI: 10.2169/internalmedicine.55.7152,   PubMed: 27803418)
98. Yasuhiko Nishioka :
Cancer immunotherapy as a promising fourth standard therapy for lung cancer: Beyond 20 years for the development of immunotherapy,
Respiratory Investigation, Vol.54, No.5, 297, 2016.
(DOI: 10.1016/j.resinv.2016.08.001,   PubMed: 27566375)
99. Hirokazu Ogino, Masaki Hanibuchi, Souji Kakiuchi, Atsuro Saijo, Toshifumi Tezuka, Yuko Toyoda, Makoto Tobiume, Kenji Otsuka, Satoshi Sakaguchi, Hisatsugu Goto, Kokichi Arisawa and Yasuhiko Nishioka :
Analysis of the prognostic factors of extensive disease small-cell lung cancer patients in Tokushima University Hospital,
The Journal of Medical Investigation : JMI, Vol.63, No.3 4, 286-293, 2016.
(徳島大学機関リポジトリ: 111196,   DOI: 10.2152/jmi.63.286,   PubMed: 27644574,   Elsevier: Scopus)
100. Shinji Abe, Kato Mika Kaneko, Yuki Tsuchihashi, Toshihiro Izumi, Satoshi Ogasawara, Naoto Okada, Chiemi Sato, Makoto Tobiume, Kenji Otsuka, Licht Miyamoto, Koichiro Tsuchiya, Kazuyoshi Kawazoe, Yukinari Kato and Yasuhiko Nishioka :
Antitumor effect of novel anti-podoplanin antibody NZ-12 against malignant pleural mesothelioma in an orthotopic xenograft model.,
Cancer Science, Vol.107, No.9, 1198-1205, 2016.
(徳島大学機関リポジトリ: 112378,   DOI: 10.1111/cas.12985,   PubMed: 27294401)
101. K Hasegawa, M Tagawa, K Takagi, H Tsukamoto, Y Tomioka, T Suzuki, Yasuhiko Nishioka, T Ohrui and M Numasaki :
Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1.,
Cancer Gene Therapy, Vol.23, No.8, 266-277, 2016.
(DOI: 10.1038/cgt.2016.29,   PubMed: 27561689)
102. Yuko Toyoda, Masaki Hanibuchi, Jun Kishi, Hiroshi Kawano, Shun Morizumi, Seidai Satou, M Kondo, Terumi Takikura, Toshifumi Tezuka, Hisatsugu Goto and Yasuhiko Nishioka :
Clinical features and outcome of acute exacerbation of interstitial pneumonia associated with connective tissue disease.,
The Journal of Medical Investigation : JMI, Vol.63, No.3,4, 294-299, 2016.
(徳島大学機関リポジトリ: 111197,   DOI: 10.2152/jmi.63.294,   PubMed: 27644575,   Elsevier: Scopus)
103. 山子 泰斗, 埴淵 昌毅, 荻野 広和, 村上 永尚, 梶 龍兒, 西岡 安彦 :
多彩な神経症状を呈した小細胞肺癌に伴う傍腫瘍性神経症候群の1例,
肺癌, Vol.56, No.3, 199-204, 2016年.
(徳島大学機関リポジトリ: 117547,   DOI: 10.2482/haigan.56.199,   CiNii: 1390001204681086464)
104. Seidai Satou, Masaki Hanibuchi, Takahashi Mikiko, Fukuda Yuh, Morizumi Shun, Yuko Toyoda, Hisatsugu Goto and Yasuhiko Nishioka :
A patient with idiopathic pleuroparenchymal fibroelastosis showing a sustained pulmonary function due to treatment with pirfenidone,
Internal Medicine, Vol.55, No.5, 497-501, 2016.
(徳島大学機関リポジトリ: 114388,   DOI: 10.2169/internalmedicine.55.5047,   PubMed: 26935370,   Elsevier: Scopus)
105. 後東 久嗣, 三橋 惇志, 西岡 安彦 :
線維細胞がかかわる血管新生阻害薬に対する獲得耐性メカニズム,
分子呼吸器病, Vol.20, No.1, 111-114, 2016年.
(CiNii: 1520010380299131392)
106. Hirokazu Ogino, Masaki Hanibuchi, Hiromitsu Takizawa, Shoji Sakiyama, Sumitomo Hiroyuki, Seiji Iwamoto, Hitoshi Ikushima, Nakajima Kohei, Shinji Nagahiro, Yamago Taito, Yuko Toyoda, Yoshimi Bando and Yasuhiko Nishioka :
Primary Pulmonary Synovial Sarcoma Showing a Prolonged Survival with Multimodality Therapy,
Internal Medicine, Vol.55, No.4, 381-387, 2016.
(徳島大学機関リポジトリ: 114387,   DOI: 10.2169/internalmedicine.55.5169,   PubMed: 26875964)
107. Muneo Numasaki, Hiroki Tsukamoto, Yoshihisa Tomioka, Yasuhiko Nishioka and Takashi Ohrui :
A Heterodimeric Cytokine, Consisting of IL-17A and IL-17F, Promotes Migration and Capillary-Like Tube Formation of Human Vascular Endothelial Cells.,
The Tohoku Journal of Experimental Medicine, Vol.240, No.1, 47-56, 2016.
(DOI: 10.1620/tjem.240.47,   PubMed: 27594509,   Elsevier: Scopus)
108. 梶田 敬介, 佐藤 正大, 豊田 優子, 坂口 暁, 手塚 敏史, 後東 久嗣, 埴淵 昌毅, 西岡 安彦 :
クリゾチニブが奏効したperformance status不良anaplastic lymphoma kinase遺伝子転座陽性肺腺癌の1例,
四国医学雑誌, Vol.71, No.5,6, 141-148, 2015年.
(徳島大学機関リポジトリ: 109939,   CiNii: 1050564287418456448)
109. Mitsuhashi Atsushi, Hisatsugu Goto, Atsuro Saijo, Trung The Van, Yoshinori Aono, Hirokazu Ogino, Kuramoto Takuya, Tabata Sho, Hisanori Uehara, Keisuke Izumi, Mitsuteru Yoshida, Kobayashi Hiroaki, Takahashi Hidefusa, Gotoh Masashi, Kakiuchi Soji, Masaki Hanibuchi, Seiji Yano, Yokomise Hiroyasu, Shoji Sakiyama and Yasuhiko Nishioka :
Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab,
Nature Communications, Vol.6, 8792, 2015.
(徳島大学機関リポジトリ: 115640,   DOI: 10.1038/ncomms9792,   PubMed: 26635184,   Elsevier: Scopus)
110. Hiroshi Kawano, Hitoshi Nishijima, Junko Morimoto, Fumiko Hirota, Ryoko Morita, Yasuhiro Mouri, Yasuhiko Nishioka and Mitsuru Matsumoto :
Aire expression is inherent to most medullary thymic epithelial cells during their differentiation program.,
The Journal of Immunology, Vol.195, No.11, 5149-5158, 2015.
(徳島大学機関リポジトリ: 109688,   DOI: 10.4049/jimmunol.1501000,   PubMed: 26503950)
111. K Fukushima, S Nakamura, Y Inoue, Y Higashiyama, M Ohmichi, T Ishida, K Yoshimura, T Sawai, N Takayanagi, C Nakahama, T Kakugawa, K Izumikawa, N Aoki, Yasuhiko Nishioka, O Kosaka and S Kohno :
Utility of a sputum antigen detection test in pneumococcal and lower respiratory infectious disease in adults,
Internal Medicine, Vol.54, No.22, 2843-2850, 2015.
(DOI: 10.2169/internalmedicine.54.4082,   PubMed: 26567996)
112. Yukinari Kato, Akiko Kunita, Shinji Abe, Satoshi Ogasawara, Yuki Fujii, Hiroharu Oki, Masashi Fukayama, Yasuhiko Nishioka and Mika K. Kaneko :
The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity,
Oncotarget, Vol.6, No.34, 36003-36018, 2015.
(徳島大学機関リポジトリ: 115672,   DOI: 10.18632/oncotarget.5339,   PubMed: 26416352,   Elsevier: Scopus)
113. Takumi Sakurada, Souji Kakiuchi, Soichiro Tajima, Yuya Horinouchi, Ken Konaka, Naoto Okada, Hirotaka Nishisako, Toshimi Nakamura, Kazuhiko Teraoka, Kazuyoshi Kawazoe, Hiroaki Yanagawa, Yasuhiko Nishioka and Keisuke Ishizawa :
Pemetrexed-induced rash may be prevented by supplementary corticosteroids,
Biological & Pharmaceutical Bulletin, Vol.38, No.11, 1752-1756, 2015.
(DOI: 10.1248/bpb.b15-00435,   PubMed: 26521826,   Elsevier: Scopus)
114. 埴淵 昌毅, 西岡 安彦 :
Current topics from major journals-英文抄読会から ALK陽性非小細胞肺癌に対する1次治療でのクリゾチニブと化学療法の比較試験,
日本胸部臨床, Vol.74, No.6, 717, 2015年.
115. Hiroshi Kawano, Masaki Hanibuchi, Yoshijima Terumi, Yuko Toyoda, Jun Kishi, Toshifumi Tezuka and Yasuhiko Nishioka :
A case of atypical Takayasu arteritis initially presenting with peripheral artery disease,
Case Reports in Clinical Pathology, Vol.2, No.2, 34-40, 2015.
(DOI: 10.5430/crcp.v2n2p34)
116. Kojiro Nagai, Jun Kishi, Shun Morizumi, Jun Minakuchi, Yoshimi Bando, Yasuhiko Nishioka and Toshio Doi :
Henoch-Schönlein purpura nephritis occurring postpartum in a patient with anti-PL-7 anti-synthetase syndrome.,
Modern Rheumatology, Vol.28, 1-4, 2015.
(DOI: 10.3109/14397595.2015.1038879,   PubMed: 25867231)
117. 中野 万有里, 吉田 成二, 中山 正, 大串 文隆, 埴淵 昌毅, 西岡 安彦 :
インフルエンザ (H1N1) 2009に伴うARDSにPMX-DHP療法が奏効した1例,
感染症学雑誌, Vol.89, No.3, 416-421, 2015年.
(DOI: 10.11150/kansenshogakuzasshi.89.416,   CiNii: 1390282680028294784,   Elsevier: Scopus)
118. 埴淵 昌毅, 大塚 憲司, 塚﨑 佑貴, 坂下 直実, 功刀 しのぶ, 福田 悠, 西岡 安彦 :
Acute fibrinous and organizing pneumoniaパターンの特発性間質性肺炎が示唆された1例,
THE LUNG perspectives, Vol.23, No.2, 2-5, 2015年.
119. Seidai Satou, Y Kawamata, A Takahashi, Y Imai, A Hanyu, A Okuma, M Takasugi, K Yamakoshi, H Sorimachi, H Kanda, Y Ishikawa, S Sone, Yasuhiko Nishioka, N Otani and E Hara :
Ablation of the p16(INK4a) tumour suppressor reverses ageing phenotypes of klotho mice,
Nature Communications, Vol.6, 7035, 2015.
(DOI: 10.1038/ncomms8035,   PubMed: 25923845)
120. H Yamazaki, R Sakai, R Koike, Y Miyazaki, M Tanaka, T Nanki, K Watanabe, S Yasuda, T Kurita, Y Kaneko, Y Tanaka, Yasuhiko Nishioka, Y Takasaki, K Nagasaka, H Nagasawa, S Thoma, M Dohi, T Sugihara, H Sugiyama, Y Kawaguchi, N Inase, S Ochi, H Hagiyama, H Kohsaka, N Miyasaka, M Harigai and Group Study PREVENT :
Assessment of Risks of Pulmonary Infection During 12 Months Following Immunosuppressive Treatment for Active Connective Tissue Diseases:A Large-scale Prospective Cohort Study,
The Journal of Rheumatology, Vol.42, No.4, 614-622, 2015.
(DOI: 10.3899/jrheum.140778,   PubMed: 25641893)
121. Takumi Sakurada, Souji Kakiuchi, Soichiro Tajima, Yuya Horinouchi, Naoto Okada, Hirotaka Nishisako, Toshimi Nakamura, Kazuhiko Teraoka, Kazuyoshi Kawazoe, Hiroaki Yanagawa, Yasuhiko Nishioka, Kazuo Minakuchi and Keisuke Ishizawa :
Characteristics and risk factors of interstitial lung disease induced by chemotherapy for lung cancer,
The Annals of Pharmacotherapy, Vol.49, No.4, 398-404, 2015.
(DOI: 10.1177/1060028014566446,   PubMed: 25565405,   Elsevier: Scopus)
122. 西岡 安彦 :
肺癌,
今日の診療のために ガイドライン外来診療2015 泉孝英編集, 570-572, 2015年.
123. Toshifumi Tezuka, Hirohisa Ogawa, Masahiko Azuma, Hisatsugu Goto, Hisanori Uehara, Yoshinori Aono, Masaki Hanibuchi, Yamaguchi Yoichi, Fujikawa Tomoyuki, Itai Akiko and Yasuhiko Nishioka :
IMD-4690, a novel specific inhibitor for plasminogen activator inhibitor-1, reduces allergic airway remodeling in a mouse model of chronic asthma via regulating angiogenesis and remodeling-related mediators,
PLoS ONE, Vol.10, No.3, e0121615, 2015.
(徳島大学機関リポジトリ: 109460,   DOI: 10.1371/journal.pone.0121615,   PubMed: 25785861,   Elsevier: Scopus)
124. Seidai Satou, Masaki Hanibuchi, Makoto Tobiume, Jun Kishi, Yuko Toyoda, Hiroshi Kawano, Mikiko Takahashi, Yuh Fukuda and Yasuhiko Nishioka :
A case of IgG4-related interstitial lung disease showing usual interstitial pneumonia pattern: Unusual case for histological features with pathological proof,
Case Reports in Clinical Pathology, Vol.2, No.1, 6-11, 2015.
(DOI: 10.5430/crcp.v2n1p6)
125. 佐藤 正大, 後東 久嗣, 阿部 秀一, 竹﨑 彰夫, 河野 弘, 青野 純典, 西岡 安彦 :
ヒトfibrocyte分化における遺伝子発現解析と分子標的治療薬による分化制御の検討,
分子呼吸器病, Vol.19, No.1, 135-139, 2015年.
(CiNii: 1520854804901101056)
126. Yoshinori Aono, Masami Kishi, Yuki Yokota, Momoyo Azuma, Katsuhiro Kinoshita, Akio Takezaki, Seidai Sato, Hiroshi Kawano, Jun Kishi, Hisatsugu Goto, Hisanori Uehara, Keisuke Izumi and Yasuhiko Nishioka :
Role of PDGF/PDGFR axis in the trafficking of circulating fibrocytes in pulmonary fibrosis,
American Journal of Respiratory Cell and Molecular Biology, Vol.51, No.6, 793-801, 2014.
(DOI: 10.1165/rcmb.2013-0455OC,   PubMed: 24885373,   Elsevier: Scopus)
127. Michi Tanaka, Ryuji Koike, Ryoko Sakai, Kazuyoshi Saito, Shintaro Hirata, Hayato Nagasawa, Hideto Kameda, Masako Hara, Yasushi Kawaguchi, Shigeto Tohma, Yoshinari Takasaki, Makoto Dohi, Yasuhiko Nishioka, Shinsuke Yasuda, Yasunari Miyazaki, Yuko Kaneko, Toshihiro Nanki, Kaori Watanabe, Hayato Yamazaki, Nobuyuki Miyasaka and Masayoshi Harigai :
Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia,
Modern Rheumatology, Vol.25, No.4, 609-614, 2014.
(DOI: 10.3109/14397595.2014.980384,   PubMed: 25496409,   Elsevier: Scopus)
128. Hirohisa Ogawa, G Julie Ledford, Sambuddho Mukherjee, Yoshinori Aono, Yasuhiko Nishioka, J James Lee, Keisuke Izumi and W John Hollingsworth :
Surfactant protein D attenuates sub-epithelial fibrosis in allergic airways disease through TGF-β.,
Respiratory Research, Vol.15, 143, 2014.
(DOI: 10.1186/s12931-014-0143-9,   PubMed: 25472740)
129. Taisuke Matsuo, Le Tan Dat, Masato Komatsu, Tetsuro Yoshimaru, Kei Daizumoto, Saburo Sone, Yasuhiko Nishioka and Toyomasa Katagiri :
Early growth response 4 is involved in cell proliferation of small cell lung cancer through transcriptional activation of its downstream genes.,
PLoS ONE, Vol.9, No.11, e113606, 2014.
(DOI: 10.1371/journal.pone.0113606,   PubMed: 25411851,   Elsevier: Scopus)
130. Seidai Satou, Masaki Hanibuchi, Asami Fukuya, Youhei Yabuki, Hiroki Bando, Terumi Yoshijima, Hisatsugu Goto, Hirohisa Ogawa and Yasuhiko Nishioka :
Idiopathic pleuroparenchymal fibroelastosis is characterized by an elevated serum level of surfactant protein-D, but not krebs von den lungen-6,
Lung, Vol.192, No.5, 711-717, 2014.
(DOI: 10.1007/s00408-014-9599-0,   PubMed: 24880792,   Elsevier: Scopus)
131. Masaki Hanibuchi, SJ Kim, IJ Fidler and Yasuhiko Nishioka :
The molecular biology of lung cancer brain metastasis: an overview of current comprehensions and future perspectives,
The Journal of Medical Investigation : JMI, Vol.61, No.3,4, 241-253, 2014.
(徳島大学機関リポジトリ: 109563,   DOI: 10.2152/jmi.61.241,   PubMed: 25264041)
132. Yuko Toyoda, Sho Tabata, Jun Kishi, Takuya Kuramoto, Atsushi Mitsuhashi, Atsuro Saijo, Hiroshi Kawano, Hisatsugu Goto, Yoshinori Aono, Masaki Hanibuchi, Hideaki Horikawa, Toshihiro Nakajima, Tatsuhiko Furukawa, Saburo Sone, Shin-ichi Akiyama and Yasuhiko Nishioka :
Thymidine Phosphorylase Regulates the Expression of CXCL10 in Rheumatoid Arthritis Fibroblast-like Synoviocytes,
Arthritis & Rheumatology, Vol.66, No.3, 560-568, 2014.
(徳島大学機関リポジトリ: 106062,   DOI: 10.1002/art.38263,   PubMed: 24574215,   Elsevier: Scopus)
133. 木下 勝弘, 青野 純典, 竹崎 彰夫, 岡﨑 弘泰, 吉嶋 輝美, 岸 昌美, 東 桃代, 岸 潤, 泉 啓介, 西岡 安彦 :
ブレオマイシン肺線維症モデルにおけるFAKシグナル阻害薬の抗線維化効果,
分子呼吸器病, Vol.18, No.1, 154-157, 2014年.
(CiNii: 1520291855460530048)
134. 中瀬 勝則, 鶴尾 美穂, 島田 久夫, 木下 成三, 豊 纒, 杉野 聡, 浦 聡明, 山下 恵実, 古味 勝美, 小田 芳栄, 服部 順子, 西岡 安彦, 埴淵 昌毅, 吾妻 雅彦 :
徳島市医師会のCOPD対策,
四国医学雑誌, Vol.69, No.5-6, 233-242, 2013年.
(徳島大学機関リポジトリ: 109731,   CiNii: 1050845762395118848)
135. 東 桃代, 中曽 亜佐美, 西野 さおり, 高開 登茂子, 先山 正二, 加藤 真介, 西岡 安彦 :
医療従事者における泡状アルコール性手指消毒剤の殺菌効果,塗布面積及び使用感に関する検討,
日本環境感染学会誌, Vol.28, No.6, 342-347, 2013年.
(DOI: 10.4058/jsei.28.342,   CiNii: 1390001205297098240)
136. Katsuhiro Kinoshita, Yoshinori Aono, Momoyo Azuma, Jun Kishi, Akio Takezaki, Masami Kishi, Hideki Makino, Hiroyasu Okazaki, Hisanori Uehara, Keisuke Izumi, Saburo Sone and Yasuhiko Nishioka :
Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice.,
American Journal of Respiratory Cell and Molecular Biology, Vol.49, No.4, 536-543, 2013.
(徳島大学機関リポジトリ: 106054,   DOI: 10.1165/rcmb.2012-0277OC,   PubMed: 23642017)
137. Jun Huang, Sho Tabata, Souji Kakiuchi, Trung Van The, Hisatsugu Goto, Masaki Hanibuchi and Yasuhiko Nishioka :
Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic target.,
Oncotarget, Vol.4, No.8, 1172-1184, 2013.
(徳島大学機関リポジトリ: 105907,   DOI: 10.18632/oncotarget.1126,   PubMed: 23896451,   Elsevier: Scopus)
138. Akifumi Honjo, Hirohisa Ogawa, Masahiko Azuma, Toshifumi Tezuka, Saburo Sone, Arya Biragyn and Yasuhiko Nishioka :
Targeted reduction of CCR4 cells is sufficient to suppress allergic airway inflammation.,
Respiratory Investigation, Vol.51, No.4, 241-249, 2013.
(徳島大学機関リポジトリ: 105964,   DOI: 10.1016/j.resinv.2013.04.007,   PubMed: 24238232)
139. Shinji Abe, Yuki Morita, Mika Kato Kaneko, Masaki Hanibuchi, Yuta Tsujimoto, Hisatsugu Goto, Souji Kakiuchi, Yoshinori Aono, Jun Huang, Seidai Sato, Masatoshi Kishuku, Yuki Taniguchi, Mami Azuma, Kazuyoshi Kawazoe, Yoshitaka Sekido, Seiji Yano, Shin-ichi Akiyama, Saburo Sone, Kazuo Minakuchi, Yukinari Kato and Yasuhiko Nishioka :
A novel targeting therapy of malignant mesothelioma using anti-podoplanin antibody,
The Journal of Immunology, Vol.190, No.12, 6239-6249, 2013.
(DOI: 10.4049/jimmunol.1300448,   PubMed: 23690472)
140. Tsukasa Okamoto, Yasunari Miyazaki, Takashi Ogura, Kingo Chida, Nobuoki Kohno, Shigeru Kohno, Hiroyuki Taniguchi, Shinobu Akagawa, Yoshiro Mochizuki, Kohei Yamauchi, Hiroki Takahashi, Takeshi Johkoh, Sakae Homma, Kazuma Kishi, Soichiro Ikushima, Satoshi Konno, Michiaki Mishima, Ken Ohta, Yasuhiko Nishioka, Nobuyuki Yoshimura, Mitsuru Munakata, Kentaro Watanabe, Yoshihiro Miyashita and Naohiko Inase :
A nationwide epidemiological survey of chronic hypersensitivity pneumonitis in Japan.,
Respiratory Investigation, Vol.51, No.3, 191-199, 2013.
(DOI: 10.1016/j.resinv.2013.03.004,   PubMed: 23978646)
141. Atsushi Mitsuhashi, Hisatsugu Goto, Takuya Kuramoto, Sho Tabata, Sawaka Yukishige, Shinji Abe, Masaki Hanibuchi, Souji Kakiuchi, Atsuro Saijo, Yoshinori Aono, Hisanori Uehara, Seiji Yano, G Julie Ledford, Saburo Sone and Yasuhiko Nishioka :
Surfactant protein A suppresses lung cancer progression by regulating the polarization of tumor-associated macrophages.,
The American Journal of Pathology, Vol.182, No.5, 1843-1853, 2013.
(徳島大学機関リポジトリ: 106071,   DOI: 10.1016/j.ajpath.2013.01.030,   PubMed: 23499372)
142. 青野 純典, 岸 昌美, 岡﨑 弘泰, 竹﨑 彰夫, 西岡 安彦 :
ブレオマイシン誘発肺線維症モデルにおけるPDGFレセプターα,β阻害抗体の抗線維化効果,
分子呼吸器病, Vol.17, No.1, 136-139, 2013年.
143. Shino Yuasa, Harutaka Yamaguchi, Yoshinori Nakanishi, Shingo Kawaminami, Ryo Tabata, Nobuhiko Shimizu, Mitsuhiro Kohno, Teruki Shimizu, Junya Miyata, Mayuko Nakayama, Jun Kishi, Yuko Toyoda, Yasuhiko Nishioka and Kenji Tani :
Treatment responses and their predictors in patients with rheumatoid arthritis treated with biological agents.,
The Journal of Medical Investigation : JMI, Vol.60, No.1-2, 77-90, 2013.
(徳島大学機関リポジトリ: 111302,   DOI: 10.2152/jmi.60.77,   PubMed: 23614915)
144. Hideki Makino, Yoshinori Aono, Momoyo Azuma, Masami Kishi, Yuki Yokota, Katsuhiro Kinoshita, Akio Takezaki, Jun Kishi, Hiroshi Kawano, Hirohisa Ogawa, Hisanori Uehara, Keisuke Izumi, Saburo Sone and Yasuhiko Nishioka :
Antifibrotic effects of CXCR4 antagonist in bleomycin-induced pulmonary fibrosis in mice.,
The Journal of Medical Investigation : JMI, Vol.60, No.1-2, 127-137, 2013.
(徳島大学機関リポジトリ: 106047,   DOI: 10.2152/jmi.60.127,   PubMed: 23614921)
145. T Yamada, S Takeuchi, N Fujita, A Nakamura, W Wang, Q Li, M Oda, T Mitsudomi, Y Yatabe, Y Sekido, J Yoshida, M Higashiyama, M Noguchi, H Uehara, Yasuhiko Nishioka, Saburo Sone and Seiji Yano :
Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations,
Oncogene, Vol.32, No.37, 4427-4435, 2012.
(DOI: 10.1038/onc.2012.446,   PubMed: 23045273,   Elsevier: Scopus)
146. 仙崎 聖子, 廣瀬 憲志, 石上 剛史, 村尾 和俊, 久保 宜明, 西岡 安彦 :
ピルフェニドンによる光線過敏症の2例,
臨床皮膚科, Vol.66, No.12, 945-948, 2012年.
(CiNii: 1390283684869687680)
147. Seidai Satou, Masaki Hanibuchi, Takuya Kuramoto, Nodoka Yamamori, Hisatsugu Goto, Hirohisa Ogawa, Atsushi Mitsuhashi, The Trung Van, Souji Kakiuchi, Shin-ichi Akiyama, Yasuhiko Nishioka and Saburo Sone :
Macrophage stimulating protein promotes liver metastases of small cell lung cancer cells by affecting the organ microenvironment.,
Clinical & Experimental Metastasis, Vol.30, No.3, 333-344, 2012.
(DOI: 10.1007/s10585-012-9540-y,   PubMed: 23011677,   Elsevier: Scopus)
148. Takuya Kuramoto, Hisatsugu Goto, Atsushi Mitsuhashi, Sho Tabata, Hirohisa Ogawa, Hisanori Uehara, Atsuro Saijo, Souji Kakiuchi, Yoichi Maekawa, Koji Yasutomo, Masaki Hanibuchi, Shin-ichi Akiyama, Saburo Sone and Yasuhiko Nishioka :
Dll4-Fc, an inhibitor of Dll4-Notch signaling, suppresses liver metastasis of small cell lung cancer cells through down-regulation of NF-kappa-B activity,
Molecular Cancer Therapeutics, Vol.11, No.12, 2578-2587, 2012.
(DOI: 10.1158/1535-7163.MCT-12-0640,   PubMed: 22989420)
149. Kato Mika Kaneko, Akiko Kunita, Shinji Abe, Yuta Tsujimoto, Masashi Fukayama, Kaoru Goto, Yoshihiko Sawa, Yasuhiko Nishioka and Yukinari Kato :
Chimeric anti-podoplanin antibody suppresses tumor metastasis through neutralization and antibody-dependent cellular cytotoxicity.,
Cancer Science, Vol.103, No.11, 1913-1919, 2012.
(DOI: 10.1111/j.1349-7006.2012.02385.x,   PubMed: 22816430)
150. 矢野 祖, 西條 敦郎, 近藤 真代, 河野 弘, 豊田 優子, 柿内 聡司, 岸 潤, 埴淵 昌毅, 古川 貴大, 藤田 浩司, 西岡 安彦 :
神経根障害で発症した神経サルコイドーシスの一例,
四国医学雑誌, Vol.68, No.3,4, 153-158, 2012年.
(徳島大学機関リポジトリ: 102837,   CiNii: 1050845763842119680)
151. Trung The Van, Masaki Hanibuchi, Hisatsugu Goto, Takuya Kuramoto, Sawaka Yukishige, Souji Kakiuchi, Seidai Sato, Satoshi Sakaguchi, Le Tan Dat, Yasuhiko Nishioka, Shin-ichi Akiyama and Saburo Sone :
SU6668, a multiple tyrosine kinase inhibitor, inhibits the progression of human malignant pleural mesothelioma in an orthotopic model,
Respirology, Vol.17, No.6, 984-990, 2012.
(DOI: 10.1111/j.1440-1843.2012.02193.x,   PubMed: 22574723)
152. Shinji Takeuchi, Wei Wang, Qi Li, Tadaaki Yamada, Kenji Kita, S Ivan Donev, Takahiro Nakamura, Kunio Matsumoto, Eiji Shimizu, Yasuhiko Nishioka, Saburo Sone, Takayuki Nakagawa, Toshimitsu Uenaka and Seiji Yano :
Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.,
The American Journal of Pathology, Vol.181, No.3, 1034-1043, 2012.
(DOI: 10.1016/j.ajpath.2012.05.023,   PubMed: 22789825)
153. Sho Tabata, Ryuji Ikeda, Masatatu Yamamoto, Tatsuhiko Furukawa, Takuya Kuramoto, Yasuo Takeda, Katsushi Yamada, Misako Haraguchi, Yasuhiko Nishioka, Saburo Sone and Shin-ichi Akiyama :
Thymidine phosphorylase enhances reactive oxygen species generation and interleukin-8 expression in human cancer cells.,
Oncology Reports, Vol.28, No.3, 895-902, 2012.
(DOI: 10.3892/or.2012.1887,   PubMed: 22751949)
154. 坂本 晋一, 梶浦 耕一郎, 滝沢 宏光, 中川 靖士, 池田 真由美, 古川 尊子, 森本 雅美, 西野 豪志, 後藤 正和, 中川 美砂子, 山本 洋太, 古北 由仁, 武知 浩和, 吉田 光輝, 川上 行奎, 田所 由紀子, 先山 正二, 近藤 和也, 坂東 良美, 岡崎 弘泰, 後東 久嗣, 西岡 安彦, 丹黒 章 :
Erlotinibでinduction therapyを行ったIIIA期非小細胞肺癌の1手術例,
四国医学雑誌, Vol.68, No.5-6, 251-256, 2012年.
(徳島大学機関リポジトリ: 110365,   CiNii: 1050282812441819136)
155. Adel Gomaa Mohammed Gabr, Hisatsugu Goto, Masaki Hanibuchi, Hirohisa Ogawa, Takuya Kuramoto, Minako Suzuki, Atsuro Saijo, Souji Kakiuchi, Van The Trung, Satoshi Sakaguchi, Yoichiro Moriya, Saburo Sone and Yasuhiko Nishioka :
Erlotinib prevents experimental metastases of human small cell lung cancer cells with no epidermal growth factor receptor expression,
Clinical & Experimental Metastasis, Vol.29, No.3, 207-216, 2012.
(DOI: 10.1007/s10585-011-9443-3,   PubMed: 22170031)
156. Yoshinori Aono, Julie G. Ledford, Sambuddho Mukherjee, Hirohisa Ogawa, Yasuhiko Nishioka, Saburo Sone, Michael F. Beers, Paul W. Noble and Jo Rae Wright :
Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.,
American Journal of Respiratory and Critical Care Medicine, Vol.185, No.5, 525-536, 2012.
(DOI: 10.1164/rccm.201103-0561OC,   PubMed: 22198976)
157. Hirohisa Ogawa, Masahiko Azuma, Hisanori Uehara, Tetsuyuki Takahashi, Yasuhiko Nishioka, Saburo Sone and Keisuke Izumi :
Nerve growth factor derived from bronchial epithelium afer chronic mite antigen exposure contributes to airway hyperresponsiveness by inducing hyperinnervaiton, and is inhibited by in vivo siRNA.,
Clinical and Experimental Allergy, Vol.42, No.3, 460-470, 2012.
(DOI: 10.1111/j.1365-2222.2011.03918.x,   PubMed: 22168511)
158. Wei Wang, Qi Li, Shinji Takeuchi, Tadaaki Yamada, Hitomi Koizumi, Takahiro Nakamura, Kunio Matsumoto, Naofumi Mukaida, Yasuhiko Nishioka, Saburo Sone, Takayuki Nakagawa, Toshimitsu Uenaka and Seiji Yano :
Met kinase inhibitor E7050 reverses three different mechanisms of hepatocyte growth factor-induced tyrosine kinase inhibitor resistance in EGFR mutant lung cancer.,
Clinical Cancer Research, Vol.18, No.6, 1663-1671, 2012.
(DOI: 10.1158/1078-0432.CCR-11-1171,   PubMed: 22317763)
159. Keiko Miyake, Kenji Tani, Souji Kakiuchi, Chiyuki Suzuka, Yuko Toyoda, Jun Kishi, Toshifumi Tezuka, Shino Yuasa, Masaki Hanibuchi, Yoshinori Aono, Yasuhiko Nishioka and Saburo Sone :
Epidermal growth factor receptor-tyrosine kinase inhibitor (gefitinib) augments pneumonitis, but attenuates lung fibrosis in response to radiation injury in rats,
The Journal of Medical Investigation : JMI, Vol.59, No.1-2, 174-185, 2012.
(徳島大学機関リポジトリ: 106019,   DOI: 10.2152/jmi.59.174,   PubMed: 22450006)
160. Le T Dat, Taisuke Matsuo, Tetsuro Yoshimaru, Souji Kakiuchi, Hisatsugu Goto, Masaki Hanibuchi, Takuya Kuramoto, Yasuhiko Nishioka, Saburo Sone and Toyomasa Katagiri :
Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice,
International Journal of Oncology, Vol.40, No.5, 1455-1469, 2012.
(DOI: 10.3892/ijo.2012.1348,   PubMed: 22294041)
161. 藤岡 啓介, 西條 敦郎, 豊田 優子, 柿内 聡司, 埴淵 昌毅, 吾妻 雅彦, 竹内 恭子, 藤井 志朗, 中村 信元, 宇高 憲吾, 賀川 久美子, 安倍 正博, 水谷 友哉, 西岡 安彦 :
皮膚ランダム生検が診断に有用であった血管内リンパ腫の一例,
四国医学雑誌, Vol.67, No.5,6, 257-262, 2011年.
(徳島大学機関リポジトリ: 97858,   CiNii: 1050001337463886208)
162. Tadaaki Yamada, Hideaki Bando, Shinji Takeuchi, Kenji Kita, Qi Li, Wei Wang, Shiro Akinaga, Yasuhiko Nishioka, Saburo Sone and Seiji Yano :
Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small-cell lung cancer cells.,
Cancer Science, Vol.102, No.12, 2157-2163, 2011.
(DOI: 10.1111/j.1349-7006.2011.02093.x,   PubMed: 21895875)
163. Qi Li, Wei Wang, Tadaaki Yamada, Kunio Matsumoto, Katsuya Sakai, Yoshimi Bando, Hisanori Uehara, Yasuhiko Nishioka, Saburo Sone, Shotaro Iwakiri, Kazumi Itoi, Teruhiro Utsugi, Kazuo Yasumoto and Seiji Yano :
Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network.,
The American Journal of Pathology, Vol.179, No.3, 1483-1493, 2011.
(DOI: 10.1016/j.ajpath.2011.05.060,   PubMed: 21763682)
164. Trung The Van, Masaki Hanibuchi, Souji Kakiuchi, Seidai Sato, Takuya Kuramoto, Hisatsugu Goto, Atsushi Mitsuhashi, Yasuhiko Nishioka, Shin-ichi Akiyama and Saburo Sone :
The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.,
Cancer Chemotherapy and Pharmacology, Vol.68, No.2, 497-504, 2011.
(DOI: 10.1007/s00280-010-1503-x,   PubMed: 21079960)
165. Rentsenkhand Batmunkh, Yasuhiko Nishioka, Yoshinori Aono, Momoyo Azuma, Katsuhiro Kinoshita, Jun Kishi, Hideki Makino, Masami Kishi, Akio Takezaki and Saburo Sone :
CCN6 as a profibrotic mediator that stimulates the proliferation of lung fibroblasts via the integrin β1/focal adhesion kinase pathway.,
The Journal of Medical Investigation : JMI, Vol.58, No.3-4, 188-196, 2011.
(徳島大学機関リポジトリ: 83833,   DOI: 10.2152/jmi.58.188,   PubMed: 21921419)
166. Hisatsugu Goto, Masaki Hanibuchi, Satoshi Sakaguchi, Takanori Kanematsu, Souji Kakiuchi, Hideki Tomimoto, Masahiko Azuma, Toshifumi Tezuka, Hiroya Tada, Yukiyo Miki, Toshimi Nakamura, Saburo Sone and Yasuhiko Nishioka :
Investigation of the outpatient chemotherapy for lung cancer patients in Tokushima University Hospital.,
The Journal of Medical Investigation : JMI, Vol.58, No.3-4, 219-226, 2011.
(徳島大学機関リポジトリ: 83836,   DOI: 10.2152/jmi.58.219,   PubMed: 21921423)
167. Hirokazu Ogino, Masaki Hanibuchi, Souji Kakiuchi, Van The Trung, Hisatsugu Goto, Kenji Ikuta, Tadaaki Yamada, Hisanori Uehara, Akihiko Tsuruoka, Toshimitsu Uenaka, Wei Wang, Qi Li, Shinji Takeuchi, Seiji Yano, Yasuhiko Nishioka and Saburo Sone :
E7080 suppresses hematogenous multiple organ metastases of lung cancer cells with nonmutated epidermal growth factor receptor.,
Molecular Cancer Therapeutics, Vol.10, No.7, 1218-1228, 2011.
(DOI: 10.1158/1535-7163.MCT-10-0707,   PubMed: 21551260)
168. Ivan S. Donev, Wei Wang, Tadaaki Yamada, Qi Li, Shinji Takeuchi, Kunio Matsumoto, Takao Yamori, Yasuhiko Nishioka, Saburo Sone and Seiji Yano :
Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancer.,
Clinical Cancer Research, Vol.17, No.8, 2260-2269, 2011.
(DOI: 10.1158/1078-0432.CCR-10-1993,   PubMed: 21220474)
169. Kenji Yokoi, David Hawke, Carol J. Oborn, Jin-Young Jang, Yasuhiko Nishioka, Dominic Fan, Seung Wook Kim, Sun-Jin Kim and Isaiah J. Fidler :
Identification and validation of SRC and phospho-SRC family proteins in circulating mononuclear cells as novel biomarkers for pancreatic cancer.,
Translational Oncology, Vol.4, No.2, 83-91, 2011.
(PubMed: 21461171,   Elsevier: Scopus)
170. Hideki Tomimoto, Masaki Hanibuchi, Fumitaka Ogushi, Yoshio Okano, Tsutomu Shinohara, Hiroyuki Doi, Akiyoshi Yamamoto, Eiji Takeuchi, Akihiko Yamamoto, Masahiko Azuma, Hiroya Tada, Takanori Kanematsu, Souji Kakiuchi, Hisatsugu Goto, Seiji Yano, Yasuhiko Nishioka and Saburo Sone :
A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer.,
Oncology Letters, Vol.2, No.3, 465-470, 2011.
(DOI: 10.3892/ol.2011.266,   PubMed: 22866104)
171. 兼松 貴則, 豊田 優子, 後東 久嗣, 阿部 秀一, 河北 直也, 先山 正二, 西岡 安彦, 曽根 三郎 :
肺多発結節病変を呈した原発性肺平滑筋肉腫の1例,
日本呼吸器学会雑誌, Vol.49, No.3, 167-171, 2011年.
(CiNii: 1572824499879832192,   Elsevier: Scopus)
172. Tohru Sakai, Sakina Furoku, Mariko Nakamoto, Emi Shuto, Toshio Hosaka, Yasuhiko Nishioka and Saburo Sone :
Soy isoflavone equol perpetuates dextran sulfate sodium-induced acute colitis in mice.,
Bioscience, Biotechnology, and Biochemistry, Vol.75, No.3, 593-595, 2011.
(DOI: 10.1271/bbb.100710,   PubMed: 21389602)
173. Jun Kishi, Yasuhiko Nishioka, Tomomi Kuwahara, Souji Kakiuchi, Momoyo Azuma, Yoshinori Aono, Hideki Makino, Katsuhiro Kinoshita, Masami Kishi, R Batmunkh, Hisanori Uehara, Keisuke Izumi and Saburo Sone :
Blockade of Th1 chemokine receptors ameliorates pulmonary granulomatosis in mice.,
The European Respiratory Journal, Vol.38, No.2, 415-424, 2011.
(DOI: 10.1183/09031936.00070610,   PubMed: 21273392,   Elsevier: Scopus)
174. Seiji Yano, Qi Li, Wei Wang, Tadaaki Yamada, Shinji Takeuchi, Emiko Nakataki, Hirokazu Ogino, Hisatsugu Goto, Yasuhiko Nishioka and Saburo Sone :
Antiangiogenic therapies for malignant pleural mesothelioma.,
Frontiers in Bioscience, Vol.16, 740-748, 2011.
(DOI: 10.2741/3716,   PubMed: 21196199)
175. Yasuhiko Nishioka, Yoshinori Aono and Saburo Sone :
Role of tyrosine kinase inhibitors in tumor immunology.,
Immunotherapy, Vol.3, No.1, 107-116, 2011.
(DOI: 10.2217/imt.10.79,   PubMed: 21174561)
176. 組橋 由記, 埴淵 昌毅, 富本 英樹, 東 桃代, 兼松 貴則, 柿内 聡司, 後東 久嗣, 多田 浩也, 西岡 安彦, 曽根 三郎 :
非小細胞肺癌患者のpatient-reported outcome(PRO)評価法の現状と問題点 ―第III 相臨床試験論文のreview―,
肺癌, Vol.50, No.6, 791-802, 2010年.
(DOI: 10.2482/haigan.50.791,   CiNii: 1390001204681018368,   Elsevier: Scopus)
177. Takanori Kanematsu, Masaki Hanibuchi, Hideki Tomimoto, Shoji Sakiyama, Koichiro Kenzaki, Kazuya Kondo, Bando Hiroyasu, Haku Takashi, Yoneda Kazuo, Hirose Toshiyuki, Toyoda Yuko, Hisatsugu Goto, Sakaguchi Satoshi, Katsuhiro Kinoshita, Momoyo Azuma, Kakiuchi Soji, Jun Kishi, Masahiko Azuma, Tada Hiroya, Sumitomo Masayuki, Yasuhiko Nishioka, Seiji Yano and Saburo Sone :
Epidemiological and clinical features of lung cancer patients from 1999 to 2009 in Tokushima Prefecture of Japan,
The Journal of Medical Investigation : JMI, Vol.57, No.3,4, 326-333, 2010.
(徳島大学機関リポジトリ: 79184,   DOI: 10.2152/jmi.57.326,   PubMed: 20847534,   Elsevier: Scopus)
178. Hirohisa Ogawa, Masahiko Azuma, S Muto, Yasuhiko Nishioka, A Honjo, T Tezuka, Hisanori Uehara, Keisuke Izumi, A Itai and Saburo Sone :
IκB kinase β inhibitor IMD-0354 suppresses airway remodelling in a Dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma,
Clinical and Experimental Allergy, Vol.41, No.1, 104-115, 2010.
(DOI: 10.1111/j.1365-2222.2010.03564.x,   PubMed: 20573155,   Elsevier: Scopus)
179. Satoshi Sakaguchi, Hisatsugu Goto, Masaki Hanibuchi, Shinsaku Otsuka, Hirokazu Ogino, Souji Kakiuchi, Hisanori Uehara, Seiji Yano, Yasuhiko Nishioka and Saburo Sone :
Gender difference in bone metastasis of human small cell lung cancer, SBC-5 cells in natural killer-cell depleted severe combined immunodeficient mice.,
Clinical & Experimental Metastasis, Vol.27, No.5, 351-359, 2010.
(DOI: 10.1007/s10585-010-9333-0,   PubMed: 20464627)
180. Tadaaki Yamada, Kunio Matsumoto, Wei Wang, Qi Li, Yasuhiko Nishioka, Yoshitaka Sekido, Saburo Sone and Seiji Yano :
Hepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibitor in EGFR-T790M mutant lung cancer.,
Clinical Cancer Research, Vol.16, No.1, 174-183, 2010.
(DOI: 10.1158/1078-0432.CCR-09-1204,   PubMed: 20008840)
181. Tohru Sakai, Sakina Furoku, Mariko Nakamoto, Emi Shuto, Toshio Hosaka, Yasuhiko Nishioka and Saburo Sone :
The Soy isoflavone equol enhances antigen-specific IgE production in ovalbumin-immunized BALB/c mice.,
Journal of Nutritional Science and Vitaminology, Vol.56, No.1, 72-76, 2010.
(DOI: 10.3177/jnsv.56.72,   PubMed: 20354350)
182. Kenji Ikuta, Seiji Yano, Van The Trung, Masaki Hanibuchi, Hisatsugu Goto, Qi Li, Wei Wang, Tadaaki Yamada, Hirokazu Ogino, Soji Kakiuchi, Hisanori Uehara, Yoshitaka Sekido, Toshimitsu Uenaka, Yasuhiko Nishioka and Saburo Sone :
E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.,
Clinical Cancer Research, Vol.15, No.23, 7229-7237, 2009.
(DOI: 10.1158/1078-0432.CCR-09-1980,   PubMed: 19934291)
183. Shinsaku Otsuka, Masaki Hanibuchi, Kenji Ikuta, Seiji Yano, Hisatsugu Goto, Hirokazu Ogino, Tadaaki Yamada, Soji Kakiuchi, Yasuhiko Nishioka, Takashi Takahashi and Saburo Sone :
A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice.,
Oncology Research, Vol.17, No.11-12, 581-591, 2009.
(DOI: 10.3727/096504009789745511,   PubMed: 19806789)
184. Akemi Sugita, Hirohisa Ogawa, Masahiko Azuma, Susumu Muto, Akifumi Honjo, Hiroaki Yanagawa, Yasuhiko Nishioka, Kenji Tani, Akiko Itai and Saburo Sone :
Antiallergic and anti-inflammatory effects of a novel IκB kinase β inhibitor, IMD-0354, in a mouse model of allergic inflammation.,
International Archives of Allergy and Immunology, Vol.148, No.3, 186-198, 2008.
(DOI: 10.1159/000161579,   PubMed: 18849610)
185. Kazuhide Yoneda, Junji Ueno, Sadamitsu Nishihara, Tetsuya Tsujikawa, Naomi Morita, Hideki Otsuka, Kaori Furutani, Hiromu Nishitani, Kazuya Kondo and Yasuhiko Nishioka :
Postprocessing technique with MDCT data improves the accuracy of the detection of lung nodules,
Radiation Medicine, Vol.25, No.10, 511-515, 2007.
(DOI: 10.1007/s11604-007-0176-9,   PubMed: 18085401,   Elsevier: Scopus)
186. M. Azuma, Yasuhiko Nishioka, Y. Aono, M. Inayama, H. Makino, Jun Kishi, Masayuki Shono, Katsuhiro Kinoshita, H. Uehara, H. ogushi, K. Izumi and Saburo Sone :
Role of 1-acid glycoprorein in theraqeutic antifibrotic effects of imatinib plus macrolides in mice.,
American Journal of Respiratory and Critical Care Medicine, Vol.176, No.12, 1243-1250, 2007.
(DOI: 10.1164/rccm.200702-178OC,   PubMed: 17717205)
187. Ali Jalili, Shuji Ozaki, Tomoko Hara, Hironobu Shibata, Toshihiro Hashimoto, Masahiro Abe, Yasuhiko Nishioka and Toshio Matsumoto :
Induction of HM1.24 peptide specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma,
Blood, Vol.106, No.10, 3538-3545, 2005.
(DOI: 10.1182/blood-2005-04-1438,   PubMed: 16037388)
188. Yoshinori Aono, Yasuhiko Nishioka, Mami Inayama, Jun Kishi, Momoyo Ugai, Hisanori Uehara, Keisuke Izumi and Saburo Sone :
Imatinib as a Novel Antifibrotic Agent in Bleomycin-induced Pulmonary Fibrosis in Mice,
American Journal of Respiratory and Critical Care Medicine, Vol.171, No.11, 1279-1285, 2005.
(DOI: 10.1164/rccm.200404-531OC,   PubMed: 15735062)
189. Yanjmaa Bira, Kenji Tani, Yasuhiko Nishioka, juuya Miyata, Keiko Sato, Akihito Hayashi, Yutaka Nakaya and Saburo Sone :
Transforming growth factor β stimulates rheumatoid synovial fibroblasts via the type receptor,
Modern Rheumatology, Vol.15, No.2, 108-113, 2005.
(DOI: 10.1007/s10165-004-0378-2,   PubMed: 17029045)
190. Masaki Hanibuchi, Yuka Matsumori, Yasuhiko Nishioka and Saburo Sone :
A case of sarcoidosis accompanying squamous cell carcinoma in the mandibular gingiva,
The Journal of Medical Investigation : JMI, Vol.52, No.1-2, 118-121, 2005.
(徳島大学機関リポジトリ: 110766,   DOI: 10.2152/jmi.52.118,   PubMed: 15751283)
191. Kazuyoshi Manabe, Yasuhiko Nishioka, Jun Kishi, Mami Inayama, Yoshinori Aono, Yoichi Nakamura, Fumitaka Ogushi, Hiroyasu Bando, Kenji Tani and Saburo Sone :
Elevation of macrophage-derived chemokine in eosinophilic pneumonia: a role of alveolar macrophages,
The Journal of Medical Investigation : JMI, Vol.52, No.1,2, 85-92, 2005.
(徳島大学機関リポジトリ: 110761,   DOI: 10.2152/jmi.52.85,   PubMed: 15751278,   CiNii: 1390001204244676736)
192. Ning Ge, Yasuhiko Nishioka, Yoichi Nakamura, Yoshio Okano, Kazuo Yoneda, Hirohisa Ogawa, Akemi Sugita, Hiroaki Yanagawa and Saburo Sone :
Synthesis and Secretion of Interleukin-15 by Freshly Isolated Human Bronchial Epithelial Cells,
International Archives of Allergy and Immunology, Vol.135, No.3, 235-242, 2004.
(DOI: 10.1159/000081309,   PubMed: 15467375)
193. Masato Okamoto, Sachiko Furuichi, Yasuhiko Nishioka, Tetsuya Oshikawa, Tomoyuki Tano, Sharif Uddin Ahmed, Kiyoshi Takeda, Shizuo Akira, Yoshiki Ryoma, Yoichiro Moriya, Motoo Saito, Saburo Sone and Mitsunobu Sato :
Expression of Toll-Like Receptor 4 on Dendritic Cells Is Significant for Anticancer Effect of Dendritic Cell-Based Immunotherapy in Combination with an Active Component of OK-432, a Streptococcal Preparation,
Cancer Research, Vol.64, No.15, 5461-5470, 2004.
(DOI: 10.1158/0008-5472.CAN-03-4005,   PubMed: 15289356)
194. Toru Asano, Fumitaka Ogushi, Kenji Tani, Hiroyuki Tamiya, Yasuhiko Nishioka and Saburo Sone :
Increased macrophage inflammatory protein-1α and -1β in BAL fluid of bronchiolitis obliterans organizing pneumonia,
Respirology, Vol.8, No.4, 461-466, 2003.
(DOI: 10.1046/j.1440-1843.2003.00496.x,   PubMed: 14629649)
195. H Ogawa, N Nishimura, Yasuhiko Nishioka, M Azuma, Hiroaki Yanagawa and Saburo Sone :
Adenoviral interleukin-12 gene transduction into human bronchial epithelial cells:up-regulation of pro-inflammatory cytokines and its prevention by corticosteroids,
Clinical and Experimental Allergy, Vol.33, No.7, 921-929, 2003.
(DOI: 10.1046/j.1365-2222.2003.01702.x,   PubMed: 12859448)
196. Seiji Yano, Yasuhiko Nishioka, Hisatsugu Goto and Saburo Sone :
Molecular mechanisms of angiogenesis in non-small cell lung cancer, and therapeutics targeting related molecules.,
Cancer Science, Vol.94, No.6, 479-485, 2003.
(DOI: 10.1111/j.1349-7006.2003.tb01469.x,   PubMed: 12824870)
197. Hiroya Tada, Fumitaka Ogushi, Kenji Tani, Yasuhiko Nishioka, Jun-ya Miyata, Keiko Sato, Toru Asano and Saburo Sone :
Increased binding and chemotactic capacities of PDGF-BB on fibroblasts in radiation pneumonitis,
Radiation Research, Vol.159, No.6, 805-811, 2003.
(DOI: 10.1667/0033-7587(2003)159[0805:IBACCO]2.0.CO;2,   PubMed: 12751964,   CiNii: 1571698601685680896)
198. Yasuhiko Nishioka, Hua Wen, Kayo Mitani, Paul D. Robbins, Michael T. Lotze, Saburo Sone and Hideaki Tahara :
Differential effects of IL-12 on the generation of alloreactive CTL mediated by murine and human dendritic cells: a critical role for nitric oxide,
Journal of Leukocyte Biology, Vol.73, No.5, 621-629, 2003.
(DOI: 10.1189/jlb.0402205,   PubMed: 12714577)
199. Kayo Mitani, Yasuhiko Nishioka, Kazue Yamabe, Hirohisa Ogawa, Toyokazu Miki, Hiroaki Yanagawa and Saburo Sone :
Soluble Fas in malignant pleural effusion and its expression in lung cancer cells,
Cancer Science, Vol.94, No.3, 302-307, 2003.
(DOI: 10.1111/j.1349-7006.2003.tb01437.x,   PubMed: 12824926)
200. 埴淵 昌毅, 島田 玲香, 西岡 安彦, 篠原 勉, 曽根 三郎 :
三尖弁感染症心内膜炎および化膿性脊椎炎に併発した敗血症性肺塞栓症の1例(症例報告),
日本呼吸器学会雑誌, Vol.41, No.5, 365-369, 2003年.
201. Hiroyoshi Sei, Atsuko Sano, Hiromi Ohno, Kazue Yamabe, Yasuhiko Nishioka, Saburo Sone and Yusuke Morita :
Age-related changes in control of blood pressure and heart rate during sleep in the rat,
Sleep, Vol.25, No.3, 279-285, 2002.
(PubMed: 12003158,   Elsevier: Scopus)
202. Takashi Itokawa, Hiroki Nokihara, Yasuhiko Nishioka, Saburo Sone, Yukihide Iwamoto, Yuji Yamada, Julie Cherrington, Gerald McMahon, Masabumi Shibuya, Michihiko Kuwano and Mayumi Ono :
Antiangiogenic Effect by SU5416 Is Partly Attributable to Inhibition of Flt-1 Receptor Signaling,
Molecular Cancer Therapeutics, Vol.1, No.5, 295-302, 2002.
(PubMed: 12489845)
203. Hirohisa Ogawa, Naoki Nishimura, Yasuhiko Nishioka, Masahiko Azuma, Hiroaki Yanagawa and Saburo Sone :
Interleukin(IL)-12 gene transduction and its functional expression into human bronchial epithelial cells (BEAS-2B) by adenovirus vector,
The Journal of Medical Investigation : JMI, Vol.49, No.1,2, 74-82, 2002.
(徳島大学機関リポジトリ: 110639,   PubMed: 11901765,   CiNii: 1050564287419556992)
204. Yasuhiko Nishioka, Wen Hua, Naoki Nishimura and Saburo Sone :
Genetic modification of dendritic cells and its application for cancer immunotherapy,
The Journal of Medical Investigation : JMI, Vol.49, No.1,2, 7-17, 2002.
(徳島大学機関リポジトリ: 110629,   PubMed: 11901764)
205. Y. Suzuki, Hiroaki Yanagawa, Yasuhiko Nishioka, N. Nishimura and Saburo Sone :
Effect generation of dendritic cells from alveolar and pleural macrophages as well as blood monocytes with lung cancer,
Lung Cancer, Vol.34, No.2, 195-205, 2001.
(DOI: 10.1016/S0169-5002(01)00234-3,   PubMed: 11679178)
206. Masaki Hanibuchi, Seiji Yano, Yasuhiko Nishioka, Hiroaki Yanagawa, Toyokazu Miki and Saburo Sone :
Immunological circumvention of multiple organ metastases of multidrug resistant human small cell lung cancer cells by mouse-human chimeric anti-ganglioside GM2 antibody KM966.,
Clinical & Experimental Metastasis, Vol.18, No.5, 353-360, 2001.
(PubMed: 11467766)
207. Yasuhiko Nishioka, Naoki Nishimura, Yoshihiro Suzuki and Saburo Sone :
Human monocyte-derived and CD83(+) blood dendritic cells enhance NK cell-mediated cytotoxicity.,
European Journal of Immunology, Vol.31, No.9, 2633-2641, 2001.
(DOI: 10.1002/1521-4141(200109)31:9<2633::AID-IMMU2633>3.0.CO;2-2,   PubMed: 11536161)
208. Naoki Nishimura, Yasuhiko Nishioka, Tsutomu Shinohara, Hirohisa Ogawa, Sayaka Yamamoto, Kenji Tani and Saburo Sone :
Novel centrifugal method for simple and highly efficient adenovirus-mediated green fluorescence protein gene transduction into human monocyte-derived dendritic cells,
Journal of Immunological Methods, Vol.253, No.1-2, 113-124, 2001.
(DOI: 10.1016/S0022-1759(01)00360-X,   PubMed: 11384673,   Elsevier: Scopus)
209. H Nokihara, Seiji Yano, Yasuhiko Nishioka, M Hanibuchi, T Higasida, T Tsuruo and Saburo Sone :
A new quinoline derivative MS-209 reverse multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells,
Japanese Journal of Cancer Research, Vol.92, No.7, 785-792, 2001.
(PubMed: 11473730,   Elsevier: Scopus)
210. Naoki Nishimura, Yasuhiko Nishioka, Tsutomu Shinohara and Saburo Sone :
Enhanced efficiency by centrifugal manipulation of adenovirus-mediated interleukin 12 gene transduction into human monocyte-derived dendritic cells.,
Human Gene Therapy, Vol.12, No.4, 333-346, 2001.
(DOI: 10.1089/10430340150503966,   PubMed: 11242526)
211. Saburo Sone, Tsutomu Shinohara, Yasuhiko Nishioka and Seiji Yano :
Symposium on molecular pathogenesis of respiratory diseases and its clinical implication. 4. Molecular pathogenesis of lung cancer and its molecular targeted therapy,
Internal Medicine, Vol.40, No.2, 167-170, 2001.
(DOI: 10.2169/internalmedicine.40.167,   PubMed: 11300157,   Elsevier: Scopus)
212. 兼松 貴則, 大串 文隆, 小川 博久, 西岡 安彦, 篠原 勉, 楊河 宏章, 曽根 三郎 :
嚢胞状変化を呈した肺サルコイドーシスの1例,
日本呼吸器学会雑誌, Vol.39, No.2, 117-121, 2001年.
213. Hiroshi Nokihara, Hiroaki Yanagawa, Yasuhiko Nishioka, Seiji Yano, Naofumi Mukaida, Kouji Matsushima and Saburo Sone :
Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice.,
Cancer Research, Vol.60, No.24, 7002-7007, 2000.
214. Naoki Nishimura, Yasuhiko Nishioka, Tsutomu Shinohara, Kenji Tani and Saburo Sone :
Down-regulation by a new anti-inflammatory compound, FR167653, of differentiation and maturation of human monocytes and bone marrow CD34(+) cells to dendritic cells,
International Journal of Immunopharmacology, Vol.22, No.7, 501-514, 2000.
215. Stephan Lang, Yoshinari Atarashi, Yasuhiko Nishioka, Joanna Stanson, Norbert Meidenbauer and Theresa L. Whiteside :
B7.1 on human carcinomas:costimulation of T cells and enhanced tumor-induced T-cell death,
The Journal of Molecular and Cellular Immunology, Vol.1, No.2, 132-143, 2000.
216. Hitoe Torisu, Mayumi Ono, Hiromaro Kiryu, Masutaka Furue, Yasukazu Ohmoto, Juichiro Nakayama, Yasuhiko Nishioka, Saburo Sone and Michihiko Kuwano :
Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL-1α,
International Journal of Cancer, Vol.85, No.2, 182-188, 2000.
(DOI: 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.0.CO;2-M,   PubMed: 10629075)
217. Masaki Hanibuchi, Yasuhiko Nishioka, Hiroaki Yanagawa, Seiji Yano, Parajuli Prahlad, Bando Masashi and Saburo Sone :
Human interferon-gamma enhances expression of ganglioside GM2 on human lung cancer cells and their susceptibility for antiganglioside GM2 monoclonal antibody-dependent cellular cytotoxicity.,
Oncology Research, Vol.12, No.4, 173-179, 2000.
(DOI: 10.3727/096504001108747657,   PubMed: 11341466,   Elsevier: Scopus)
218. Yasuhiko Nishioka, Motohiro Hirao, Paul D. Robbins, Michael T. Lotze and Hideaki Tahara :
Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12.,
Cancer Research, Vol.59, No.16, 4035-4041, 1999.
(PubMed: 10463604,   CiNii: 1570009751812374016,   Elsevier: Scopus)
219. Seiji Yano, Masaki Hanibuchi, Yasuhiko Nishioka, Hiroshi Nishihara, Naoki Nishimura, Takashi Tsuruo and Saburo Sone :
Combined therapy with anti-p-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in nk cell-depleted scid mice,
International Journal of Cancer, Vol.82, No.1, 105-111, 1999.
(DOI: 10.1002/(SICI)1097-0215(19990702)82:1<105::AID-IJC18>3.0.CO;2-C,   PubMed: 10360828)
220. Prahlad Parajuli, Yasuhiko Nishioka, Naoki Nishimura, Sukh Mahendra Singh, Masaki Hanibuchi, Hiroshi Nokihara, Hiroaki Yanagawa and Saburo Sone :
Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing.,
Journal of Leukocyte Biology, Vol.65, No.6, 764-760, 1999.
(DOI: 10.1002/jlb.65.6.764,   PubMed: 10380897,   Elsevier: Scopus)
221. Hiroshi Nokihara, Yasuhiko Nishioka, Seiji Yano, Naofumi Mukaida, Kouji Matsushima, Takashi Tsuruo and Saburo Sone :
Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice,
International Journal of Cancer, Vol.80, No.5, 773-780, 1999.
(DOI: 10.1002/(SICI)1097-0215(19990301)80:5<773::AID-IJC23>3.0.CO;2-E,   PubMed: 10048981)
222. Prahlad Parajuli, Seiji Yano, Yasuhiko Nishioka, Hiroshi Nokihara, Masaki Hanibuchi, Naoki Nishimura, Teruhiro Utsugi and Saburo Sone :
Therapeutic Efficacy of a New Topoisomerase I and II Inhibitor TAS-103, Against Both P-Glycoprotein Expressing and Non-expressing Drug-Resistant Human Small-Cell Lung Cancer,
Oncology Research, Vol.11, No.5, 219-224, 1999.
(PubMed: 10608616)
223. Saburo Sone, Seiji Yano, Masaki Hanibuchi, Hiroshi Nokihara, Naoki Nishimura, Toyokazu Miki, Yasuhiko Nishioka and Tsutomu Shinohara :
Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice,
Cancer Chemotherapy and Pharmacology, Vol.43, No.Supplement 1, S26-S31, 1999.
(PubMed: 10357555)
224. Takuya Takayama, Yasuhiko Nishioka, Lina Lu, Michael T. Lotze, Hideaki Tahara and Angus W. Thomson :
Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness,
Transplantation, Vol.66, No.12, 1567-1574, 1998.
225. Masaki Hanibuchi, Seiji Yano, Yasuhiko Nishioka, Hiroaki Yanagawa, Tetsuya Kawano and Saburo Sone :
Therapeutic efficacy of mouse-human chimeric anti-ganglioside GM2 monoclonal antibody against multiple organ micrometastases of human lung cancer in NK cell-depleted SCID mice,
International Journal of Cancer, Vol.78, No.4, 480-485, 1998.
(DOI: 10.1002/(SICI)1097-0215(19981109)78:4<480::AID-IJC14>3.0.CO;2-A,   PubMed: 9797137)
226. Seiji Yano, Hiroaki Yanagawa, Masaki Hanibuchi, Kalpana Pai, Yasuhiko Nishioka, Takashi Tsuruo and Saburo Sone :
The role of cyclosporin A on antibody-dependent monocyte-mediated cytotoxicity against human multidrug-resistant cancer cells,
The Journal of Medical Investigation : JMI, Vol.44, No.3-4, 185-191, 1998.
(徳島大学機関リポジトリ: 110665,   PubMed: 9597807)
227. Yasuhiko Nishioka, Seiji Yano, Fujio Fujiki, Naofumi Mukaida, Kouji Matsushima, Takashi Tsuruo and Saburo Sone :
Combined therapy of multidrug-resistant human lung cancer with anti-P-glycoprotein antibody and monocyte chemoattractant protein-1 gene transduction: The possibility of immunological overcoming of multidrug resistance,
International Journal of Cancer, Vol.71, No.2, 170-177, 1997.
(DOI: 10.1002/(SICI)1097-0215(19970410)71:2<170::AID-IJC8>3.0.CO;2-Y,   PubMed: 9139838)
228. Seiji Yano, Yasuhiko Nishioka, Hiroshi Nokihara and Saburo Sone :
Macrophage colony-stimulating factor gene transduction into human lung cancer cells differentially regulates metastasis formations in various organ microenvironments of natural killer cell-depleted SCID mice,
Cancer Research, Vol.57, No.4, 784-790, 1997.
(PubMed: 9044861)
229. Seiji Yano, Hiroaki Yanagawa, Yasuhiko Nishioka, Naofumi Mukaida, Kouji Matsushima and Saburo Sone :
T helper 2 cytokines differently regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages,
The Journal of Immunology, Vol.157, No.6, 2660-2665, 1996.
(PubMed: 8805671)
230. Seiji Yano, Yasuhiko Nishioka, K Izumi, Takashi Tsuruo, T Tanaka, M Miyasaka and Saburo Sone :
Novel metastasis model of human lung cancer in SCID mice depleted of NK cells,
International Journal of Cancer, Vol.67, No.2, 211-217, 1996.
(DOI: 10.1002/(SICI)1097-0215(19960717)67:2<211::AID-IJC11>3.0.CO;2-E,   PubMed: 8760590)
231. Saburo Sone, Takashi Tsuruo, S Sato, Seiji Yano, Yasuhiko Nishioka and Tsutomu Shinohara :
Transduction of the macrophage colony-stimulating factor gene into human multidrug resistant cancer cells: enhanced therapeutic efficacy of monoclonal anti-P-glycoprotein antibody in nude mice,
Japanese Journal of Cancer Research, Vol.87, No.7, 757-764, 1996.
(DOI: 10.1111/j.1349-7006.1996.tb00289.x,   PubMed: 8698627)
232. Masaki Hanibuchi, Seiji Yano, Yasuhiko Nishioka, Hiroaki Yanagawa and Saburo Sone :
Anti-ganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes,
Japanese Journal of Cancer Research, Vol.87, No.5, 497-504, 1996.
(DOI: 10.1111/j.1349-7006.1996.tb00251.x,   PubMed: 8641987)
233. Masaharu Kan, Fumihiko Kanai, Mitsuru Iida, Hideaki Jinnouchi, Mikio Todaka, Takanobu Imanaka, Kimio Ito, Yasuhiko Nishioka, Tetsuo Ohnishi, Seika Kamohara, Hideaki Hayashi, Takashi Murakami, Susumu Kagawa, Hiroyuki Sano, Naotake Hashimoto, Sho Yoshida, Hideichi Makino and Yousuke Ebina :
Frequency of Mutations of Insulin Receptor Gene in Japanese Patients with NIDDM,
Diabetes, Vol.44, No.9, 1081-1086, 1995.
(DOI: 10.2337/diab.44.9.1081,   PubMed: 7657032)
234. Seiji Yano, Saburo Sone, Yasuhiko Nishioka, Naofumi Mukaida, Kouji Matsushima and Takeshi Ogura :
Differential effects of anti-inflammatory cytokines (IL-4, IL-10 and IL-13) on tumoricidal and chemotactic properties of human monocytes induced by monocyte chemotactic and activating factor.,
Journal of Leukocyte Biology, Vol.57, No.2, 303-309, 1995.
(DOI: 10.1002/jlb.57.2.303,   PubMed: 7852846)
235. Roustem Nabioullin, Saburo Sone, Kazuto Mizuno, Seiji Yano, Yasuhiko Nishioka, Takashi Haku and Takeshi Ogura :
Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages,
Journal of Leukocyte Biology, Vol.55, No.4, 437-442, 1994.
(DOI: 10.1002/jlb.55.4.437,   PubMed: 8145013,   Elsevier: Scopus)
236. Saburo Sone, E Orino, Kazuto Mizuno, Seiji Yano, Yasuhiko Nishioka, Takashi Haku, A Nii and Takeshi Ogura :
Production of IL-1 and its receptor antagonist is regulated differently by IFN-gamma and IL-4 in human monocytes and alveolar macrophages,
The European Respiratory Journal, Vol.7, No.4, 657-663, 1994.
(PubMed: 8005245)
237. Seiji Yano, Saburo Sone, Yasuhiko Nishioka, M Naito, Takashi Tsuruo and Takeshi Ogura :
Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes,
Japanese Journal of Cancer Research, Vol.85, No.2, 194-203, 1994.
(DOI: 10.1111/j.1349-7006.1994.tb02082.x,   PubMed: 7511575)
238. Fumihiko Kanai, Yasuhiko Nishioka, Hideki Hayashi, Seika Kamohara, Mikio Todaka and Yousuke Ebina :
Direct demonstration of insulin-induced GLUT4 translocation to the surface of intact cells by insertion of a c-myc epitope into an exofacial GLUT4 domain.,
The Journal of Biological Chemistry, Vol.268, No.19, 14523-14526, 1993.
239. Hideki Hayashi, Yasuhiko Nishioka, Seika Kamohara, Fumihiko Kanai, Kazuo Ishii, Yasuhisa Fukui, Futoshi Shabisaki, Tadaomi Takenawa, Hiroshi Kido, Nobuhiko Katsunuma and Yousuke Ebina :
The alpha-Type 85-kDa subunit of Phosphatidylinositol 3-Kinase is Phosphorylatedat Tyrosines 368, 580, and 607 by the Insulin Receptor,
The Journal of Biological Chemistry, Vol.268, No.10, 7107-7117, 1993.
240. Hideki Hayashi, Seika Kamohara, Yasuhiko Nishioka, Fumihiko Kanai, Noriaki Miyake, Yasuhisa Fukui, Futoshi Shibasaki, Tadaomi Takenawa and Yousuke Ebina :
Insulin treatment stimulates the tyrosine phosphorylation of the alpha-type 85-kDa subunit of phosphatidylinositol 3-kinase in vivo.,
The Journal of Biological Chemistry, Vol.267, No.31, 22575-22580, 1992.
241. 曽根 三郎, 仁井 昌彦, 西岡 安彦, 折野 悦子, 前田 健一, 水野 和人, 小倉 剛 :
ヒト単球・マクロファージの機能発現とIL-4による制御,
日本網内系学会誌, Vol.32, No.4, 321-324, 1992年.
(DOI: 10.3960/jslrt1961.32.321)
242. Yasuhiko Nishioka, Saburo Sone, E. Orino, A. Nii and T. Ogura :
Down-regulation by interleukin 4 of activation of human alveolar macrophages to the tumoricidal state,
Cancer Research, Vol.51, No.20, 5526-5531, 1991.
243. Saburo Sone, Eiji Kunishige, Farid Fawzy, Hiroaki Yanagawa, Akihiko Nii, Kenichi Maeda, Shinji Atagi, Yuji Heike, Yasuhiko Nishioka, Kazuhito Mizuno and Takeshi Ogura :
Interleukin-2-inducible killer activity and its regulation by blood monocyte from autologous lymphocytes of lung cancer patigents,
Japanese Journal of Cancer Research, Vol.82, No.6, 716-723, 1991.
(DOI: 10.1111/j.1349-7006.1991.tb01908.x,   PubMed: 1649813,   Elsevier: Scopus)
244. 曽根 三郎, 楊河 宏章, 福田 克之, 中西 美枝, Singh M. Sukh, 稲村 典昭, 前田 健一, 大久保 明夫, 西岡 安彦, 安宅 信二, 小倉 剛 :
ヒト単球-マクロファージのIL-2活性化キラー(LAK)発現調節におけるGM-CSFの役割,
BIOTHERAPY, Vol.4, No.3, 342-346, 1990年.
245. 稲村 典昭, 曽根 三郎, 大久保 明夫, 中西 美枝, 前田 健一, 西岡 安彦, 小倉 剛 :
ヒト末梢血単球のgranulocyte-macrophage colony-stimulating factorに対する反応性,
医学のあゆみ, Vol.151, No.8, 461-462, 1989年.
246. 大久保 明夫, 曽根 三郎, 福田 克之, 中西 美枝, 前田 健一, 西岡 安彦, 山下 親正, 小倉 剛 :
肺癌患者肺胞マクロファージの腫瘍壊死因子産生能,
医学のあゆみ, Vol.151, No.2, 127-128, 1989年.

学術論文(紀要・その他):

1. 矢葺 洋平, 大塚 憲司, 竹内 栄治, 葉久 貴司, 兼松 貴則, 西村 直樹, 豊田 優子, 埴淵 昌毅, 軒原 浩, 西岡 安彦 :
高齢者進行・再発非小細胞肺癌に対する Pemetrexed + Bevacizumab 併用療法の有効性と安全性の検討,
第62回日本肺癌学会学術集会, 2021年.
2. 後東 久嗣, 青野 純典, 西岡 安彦 :
肺の生体防御機構におけるサーファクタント蛋白Aの役割,
日本肺サーファクタント·界面医学会雑誌, Vol.43, 9-15, 2012年.
(CiNii: 1570572701190395520)

学術レター:

1. 庄野 文章, 西岡 安彦, 清水 一郎, 田代 征記, 濱 佳子, 伊東 進, 水口 和生 :
徳島大学医学部附属病院における抗菌薬適正使用の取り組みと使用状況,
医療薬学, Vol.29, No.5, 611-615, 2003年.
(DOI: 10.5649/jjphcs.29.611,   CiNii: 1390282679752865920)

総説・解説:

1. 三橋 惇志, 西岡 安彦 :
1細胞解析による腫瘍内fibrocyteの同定,
細胞, Vol.55, No.1, 55-59, 2023年6月.
2. 佐藤 正大, 西岡 安彦 :
PF-ILDと抗線維化薬について,
日本臨牀, Vol.81, No.5, 764-770, 2023年5月.
3. 西岡 安彦, 佐藤 正大 :
特発性間質性肺炎(IIPs)・肺線維症,
日本医事新報, Vol.5157, 42-43, 2023年2月.
4. 豊田 優子, 西岡 安彦 :
全身性エリテマトーデス,
呼吸器内科, Vol.42, No.6, 616-621, 2022年12月.
5. 西岡 安彦, 村上 行人, 小山 壱也, 佐藤 正大 :
肺線維化機序,
日本臨牀, Vol.80, No.9, 1351-1355, 2022年9月.
6. 村上 行人, 西岡 安彦 :
びまん性肺疾患の病態から考察するMDD診断の重要性について,
呼吸器内科, Vol.41, No.2, 142-148, 2022年2月.
(CiNii: 1522262181157043456)
7. 荻野 広和, 西岡 安彦 :
間質性肺炎合併非小細胞肺癌に対する薬物療法について,
BIO Clinica, Vol.36, No.11, 41-47, 2021年10月.
8. 小山 壱也, 西岡 安彦 :
肺の線維化 : 肺線維症と抗線維化薬 (特集 組織の線維化),
臨床免疫·アレルギー科, Vol.76, No.2, 139-146, 2021年8月.
(CiNii: 1521136281215665152)
9. 佐藤 正大, 西岡 安彦 :
間質性肺炎,
レジデントノート, Vol.23, No.8, 77-84, 2021年8月.
10. 西岡 安彦 :
免疫チェックポイント阻害薬によるがん医療,
日本内科学会雑誌, Vol.110, No.3, 520-525, 2021年3月.
(CiNii: 1520009409715539200)
11. 河野 弘, 西岡 安彦 :
グッドパスチャー症候群,
日本医師会雑誌, Vol.149, No.2, 244-246, 2020年10月.
12. 西岡 安彦 :
間質性肺炎:診断と治療の最前線,
日本内科学会雑誌, Vol.109, No.9, 1899-1905, 2020年9月.
(DOI: 10.2169/naika.109.1899,   CiNii: 1390007857411974144)
13. 三橋 惇志, 西岡 安彦 :
血管新生阻害剤に対する耐性獲得メカニズム,
実験医学, Vol.38, No.15, 157-162, 2020年9月.
(CiNii: 1010853567272655106)
14. 軒原 浩, 西岡 安彦 :
間質性肺炎合併非小細胞肺癌の治療戦略,
肺癌, Vol.60, No.2, 74-80, 2020年4月.
(DOI: 10.2482/haigan.60.74,   CiNii: 1390848250109705088)
15. 佐藤 正大, 西岡 安彦 :
特発性肺線維症の血清学的所見,
薬局, Vol.71, No.3, 26-31, 2020年3月.
16. 西岡 安彦 :
特発性肺線維症のガイドラインの変遷,
薬局, Vol.71, No.3, 16-20, 2020年3月.
17. 佐藤 正大, 西岡 安彦, Martin Kolb :
線維化肺組織の細胞外基質が線維細胞のmiR-21発現に及ぼす影響の検討,
分子呼吸器病, Vol.24, No.1, 76-79, 2020年3月.
(CiNii: 1522825129960952064)
18. 豊田 優子, 佐藤 正大, 河野 弘, 西岡 安彦 :
関節リウマチ治療薬と肺病変,
呼吸器内科, Vol.36, No.6, 618-626, 2019年12月.
(CiNii: 1523388080905010944)
19. 西岡 安彦 :
最新醫學の編集委員を担当して,
最新医学, Vol.74, No.6, 125, 2019年6月.
20. 後東 久嗣, 吾妻 雅彦, 中瀬 勝則, 豊﨑 纒, 宇都宮 正登, 西岡 安彦 :
COPD・肺がんにならないために,
四国医学雑誌, Vol.75, No.1,2, 23-30, 2019年4月.
(徳島大学機関リポジトリ: 113743,   CiNii: 1050282813476936320)
21. 西岡 安彦 :
肺がん腫瘍環境におけるfibrocyte-like cellの病的意義,
炎症と免疫, Vol.27, No.3, 31-35, 2019年4月.
22. 河野 弘, 西岡 安彦 :
間質性肺炎・慢性閉塞性肺疾患,
薬局, Vol.70, No.5, 85-90, 2019年4月.
23. 三橋 惇志, 西岡 安彦 :
免疫チェックポイント阻害薬の効果を増強する併用療法,
分子呼吸器病, Vol.23, No.1, 49-53, 2019年3月.
(CiNii: 1521417755561804800)
24. 小山 壱也, 西岡 安彦 :
テロメア伸長と肺線維症,
呼吸器内科, Vol.34, No.3, 300-303, 2018年9月.
25. 荻野 広和, 後東 久嗣, 西岡 安彦 :
咳嗽の原因として見逃してはならない腫瘍,
呼吸器ジャーナル, Vol.66, No.3, 458-465, 2018年8月.
26. 豊田 優子, 西岡 安彦 :
薬剤性肺障害,
呼吸器内科, Vol.34, No.Suppl.1, 454-461, 2018年7月.
27. 豊田 優子, 西岡 安彦 :
ニンテダニブ単独療法,
呼吸器ジャーナル, Vol.66, No.2, 229-235, 2018年5月.
28. 西岡 安彦 :
間質性肺炎の診断と治療∼最近の進歩∼,
日本内科学会雑誌, Vol.107, No.3, 54-55, 2018年3月.
29. 後東 久嗣, 西條 敦郎, 西岡 安彦 :
がんの進展における線維細胞の機能と役割∼血管新生阻害薬耐性とがん幹細胞様細胞の誘導∼,
分子呼吸器病, Vol.22, No.1, 49-51, 2018年3月.
30. 森住 俊, 河野 弘, 豊田 優子, 小山 壱也, 西村 春佳, 香川 耕造, 後東 久嗣, 西岡 安彦 :
ブレオマイシン肺線維症モデルにおける線維芽細胞増殖因子受容体阻害薬の抗線維化効果の検討,
分子呼吸器病, Vol.22, No.1, 96-98, 2018年3月.
(CiNii: 1520573330524696832)
31. Hisatsugu Goto and Yasuhiko Nishioka :
Fibrocytes: A Novel Stromal Cells to Regulate Resistance to Anti-Angiogenic Therapy and Cancer Progression,
International Journal of Molecular Sciences, Vol.19, No.1, 98, Jan. 2018.
(徳島大学機関リポジトリ: 112410,   DOI: 10.3390/ijms19010098,   PubMed: 29286323,   Elsevier: Scopus)
32. 荻野 広和, 西岡 安彦 :
がん転移の臨床研究の歴史と展望,
日本臨牀, Vol.75, No.8, 15-20, 2017年11月.
33. 豊田 優子, 西岡 安彦 :
Precision Medicine;コンパニオン診断と特発性肺線維症,
呼吸器内科, Vol.32, No.3, 292-299, 2017年9月.
34. 西岡 安彦, 阿部 真治 :
ポドプラニンを標的とした悪性胸膜中皮腫に対する新規抗体医薬開発,
生化学, Vol.89, No.4, 564-567, 2017年8月.
(DOI: 10.14952/SEIKAGAKU.2017.890564,   CiNii: 1390283684847016832,   Elsevier: Scopus)
35. 大塚 憲司, 西岡 安彦 :
肺癌における標準治療としての免疫チェックポイント阻害薬,
癌と化学療法, Vol.44, No.8, 655-660, 2017年8月.
36. 後東 久嗣, 西岡 安彦 :
血管新生阻害薬耐性のメカニズム,
日本臨牀, Vol.75, No.7, 1039-1043, 2017年7月.
37. 後東 久嗣, 西岡 安彦 :
線維細胞による肺がんに対する血管新生阻害薬の耐性メカニズム,
最新医学, Vol.72, No.4, 132-137, 2017年4月.
38. 豊田 優子, 西岡 安彦 :
間質性肺炎のバイオマーカーの探索と活用法,
Medical Ptactice, Vol.34, No.4, 627-628, 2017年4月.
39. 後東 久嗣, 三橋 惇志, 西岡 安彦 :
血管新生阻害薬耐性とfibrocyte,
分子呼吸器病, Vol.21, No.1, 4-7, 2017年3月.
40. 岡﨑 弘泰, 西岡 安彦 :
加齢と肺線維化,
The Lung Perspectives, Vol.24, No.3, 50-54, 2016年8月.
41. 埴淵 昌毅, 西岡 安彦 :
特集 COPD合併肺癌: 病因論から治療まで. COPDにおける肺癌合併の分子機構,
呼吸と循環, Vol.64, No.8, 743-747, 2016年8月.
(CiNii: 1390565159920348544)
42. 西岡 安彦 :
間質性肺炎 Update 序論,
最新医学, Vol.71, No.7, 1233-1234, 2016年7月.
43. 吾妻 安良太, 小倉 高志, 西岡 安彦 :
間質性肺炎 Update 座談会 抗線維化薬時代の間質性肺炎診療を考える,
最新医学, Vol.71, No.7, 1235-1248, 2016年7月.
44. 河野 弘, 西岡 安彦 :
膠原病における肺病変へのアプローチ,
リウマチ科, Vol.55, No.4, 345-352, 2016年4月.
45. 佐藤 正大, 西岡 安彦 :
ニンテダニブ 新薬の最近の話題,
分子呼吸病, Vol.20, No.1, 100-102, 2016年3月.
46. 佐藤 正大, 大谷 直子, 原 英二, 西岡 安彦 :
がん抑制遺伝子による細胞と個体老化の制御,
がん分子標的治療, Vol.14, No.1, 76-81, 2016年3月.
47. 後東 久嗣, 青野 純典, 三橋 惇志, 西岡 安彦 :
慢性炎症とfibrocyte,
呼吸と循環, Vol.64, No.2, 149-155, 2016年2月.
(CiNii: 1390002209966590976)
48. 西岡 安彦, 佐藤 正大 :
ニンテダニブ,
分子呼吸器病, Vol.20, No.1, 100-102, 2016年.
49. Yasuhiko Nishioka :
Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis,
Core Evidence, Vol.10, 89-98, Aug. 2015.
(DOI: 10.2147/CE.S82905,   PubMed: 26346347)
50. 西岡 安彦 :
IPFの病因論,
THE LUNG perspective, Vol.23, No.3, 66-69, 2015年8月.
51. 埴淵 昌毅, 西岡 安彦 :
Current topics from major journals―英文抄読会から ALK陽性非小細胞肺癌に対する1次治療でのクリゾチニブと化学療法の比較試験,
日本胸部臨床, Vol.74, No.6, 717, 2015年6月.
52. 西岡 安彦 :
薬物療法におけるステロイドの位置づけとは?,
Modern Physician 6, Vol.35, No.6, 766-768, 2015年6月.
53. 西岡 安彦 :
肺線維症,
呼吸と循環, Vol.63, No.4, 315-322, 2015年4月.
(CiNii: 1390002209967124736)
54. 西岡 安彦, 阿部 秀一, 佐藤 正大, 後東 久嗣 :
Fibroocyte,
Respiratory Medical Reserch, Vol.3, No.2, 60-63, 2015年4月.
55. 西岡 安彦 :
がん免疫療法の過去と未来:エビデンスが示した新たな可能性,
日本口腔科学会雑誌, Vol.64, No.1, 1-11, 2015年3月.
56. 埴淵 昌毅, 西岡 安彦 :
抗がん剤の副作用と支持療法―より適切な抗がん剤の安全使用をめざして― III. 抗がん剤の副作用に対する評価と処置 4.抗がん剤の副作用の予防的治療,
日本臨牀, Vol.73, No.Suppl. 2, 93-97, 2015年2月.
57. 西岡 安彦, 後東 久嗣, 埴淵 昌毅, 柿内 聡司 :
呼吸器抄読会,
呼吸, Vol.34, No.2, 233, 2015年2月.
58. 後東 久嗣, 西岡 安彦 :
血管新生阻害剤に対する耐性メカニズム,
医学のあゆみ, Vol.252, No.7, 814-818, 2015年2月.
59. 豊田 優子, 河野 弘, 西岡 安彦 :
間質性肺炎の免疫療法は有効か?,
呼吸器内科, Vol.28, No.6, 451-455, 2015年.
60. 西岡 安彦 :
COPD診療の現状と徳島県での取り組み,
阿南医報, Vol.175, 20-21, 2014年10月.
61. 西岡 安彦 :
肺線維症と増殖因子シグナル,
呼吸と循環, Vol.62, No.9, 873-878, 2014年9月.
(CiNii: 1390565159920649344,   Elsevier: Scopus)
62. Yasuhiko Nishioka :
Physician scientists in respiratory medicine,
Respiratory Investigation, Vol.52, No.5, 279, Sep. 2014.
(DOI: 10.1016/j.resinv.2014.07.001,   PubMed: 25169842)
63. 西岡 安彦 :
新薬治療薬の開発状況と将来展望,
日本医師会雑誌, Vol.143, No.5, 1011, 2014年8月.
64. 後東 久嗣, 西岡 安彦 :
新薬の最近の話題「デノスマブ」,
分子呼吸器病, Vol.18, No.1, 109-111, 2014年3月.
65. 後東 久嗣, 西岡 安彦 :
新薬の最近の話題「デノスマブ」,
分子呼吸器病, Vol.18, No.1, 109-111, 2014年3月.
66. Hisatsugu Goto, Atsushi Mitsuhashi and Yasuhiko Nishioka :
Role of surfactant protein A in non-infectious lung diseases,
The Journal of Medical Investigation : JMI, Vol.61, No.1,2, 1-6, Feb. 2014.